BAYER INC. and BAYER INTELLECTUAL PROPERTY GMBH v. TEVA CANADA LMT.
Summary of T-1960-18
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Patented Medicines (NOC) Regulations [Actions]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| BAYER INC | Gowling WLG (Canada) LLP | VAN BARR, CHRISTOPHER C |
| BAYER INC | ||
| BAYER INTELLECTUAL PROPERTY GMBH | ||
| TEVA CANADA LMT |
| Name | Number |
|---|---|
| 2547113 | |
| 2823159 |
Patented Medicine: Rivaroxaban (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Bayer Inc. v. Apotex Inc. 2019 FC 191 | Feb 14, 2019 | At issue before the Court is whether the trials in two separate actions instituted by the same Plaintiffs against two different generics pursuant to the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 should be scheduled to be heard, in part, together and whether doing so offends the prohibition against joinder of actions set out in s 6.02 of the Regulations. For the reasons that follow, the Court determines that ordering the common invalidity issues in both actions to be heard together is in the interest of justice in the circumstances of this case and does not constitute a joinder of the actions. |
| Bayer Inc. v. Teva Canada Limited 2019 FC 1039 | Aug 1, 2019 | The question before the Court is whether to add Taro Pharmaceuticals Inc. (Taro) and Sandoz Canada Inc. (Sandoz) as Defendants in the trial of common issues currently set for Bayer Inc. and Bayer Intellectual Property GMBH’s (Bayer) claims against Teva Canada Limited (Teva) and Apotex Inc. (Apotex). The Bayer claims against Taro and Sandoz relate to the same drug, the same patents, and same issues of invalidity as those raised in the Teva and Apotex actions. The difference between the actions is primarily a question of timing. The Teva and Apotex actions were commenced within a month of each other, while the Taro and Sandoz actions were not launched until approximately four and six months later, respectively. |
| Bayer inc v. Apotex inc 2020 FC 325 | Mar 3, 2020 | These reasons are issued in the context of an action for patent infringement brought pursuant to s 6(1) of the Patented Medicines (Notice of Compliance) Regulations. In the course of hearing motions to rule on objections to discovery questions, I made a number of rulings on questions seeking “the position” of the plaintiffs (“Bayer”) on issues raised in the action. I upheld most of Bayer’s objections, on the basis that the questions improperly sought opinions or particulars of pleadings. I gave brief reasons at the hearing, but indicated that I would issue detailed reasons at a later date. The following are those reasons. ... What the defendants seek to elicit by those questions is how Bayer, through its counsel and experts, intends to interpret or put together these facts at trial to prove or argue that the patents are valid. ... Counsel’s arguments at the hearing at times appeared to reflect a common misconception amongst members of the bar to the effect that motions for particulars are seldom granted by the Court and that a party loses the right to obtain particulars as soon as it has pleaded over. That belief is correct only insofar as it applies to requests for particulars for the purpose of pleading. However, it has long been recognized that particulars may be sought at different times in the course of a proceeding, and that at each stage, they serve different needs and their availability obey different criteria. |
| Bayer Inc. v. Teva Canada Limited 2019 FC 1370 | Oct 31, 2019 | [Note: this decision is from 2019 but only published now] The Plaintiffs, Bayer Inc. and Bayer Intellectual Property GmbH (Bayer) brought a motion pursuant to Rule 220(1)(b)... to determine whether they require leave of the Court to rely on certain evidence of studies of their patented drug, rivaroxaban, at the trial ... The Defendants take the position that the Notice to the Profession on Experimental Testing (Notice) issued by the Chief Justice on behalf of the Court applies to this testing ... For the reasons set out below, I am not persuaded that the Notice applies in these circumstances. However, the question of whether Bayer can rely on the test results at trial is not closed, since the issue may be argued by the parties at trial. ... Bayer argues that the Notice does not apply to the evidence it intends to introduce because the testing was done before the commencement of the litigation. |
Appeals
The following appeals were taken from decision on this proceeding: [List of appeals is based on automated analysis and should not be relied upon.]
- A-388-19 is an appeal from 2019 FC 1039
- A-389-19 is an appeal from 2019 FC 1039
- A-15-20 is an appeal from a decision dated 2019-10-31
Docket Summary (Google Translate to English)
(169) 2021-12-10 - OttawaCertified French language Translation of Reasons for Order and Order rendered on 31-OCT-2019 by The Honourable Mr. Justice Pentney filed on 10-DEC-2021 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1519 page(s) 248 - 250 and copy placed on file.
Transcript of hearing held In Camera at Ottawa on 11-SEP-2020 filed on 11-SEP-2020 Sent directly to presiding Judge 21 pages (including covering pages).
Transcript of hearing held at Ottawa on 11-SEP-2020 filed on 11-SEP-2020 Sent directly to presiding Judge 42 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 10-SEP-2020 filed on 10-SEP-2020 Sent directly to presiding Judge 99 pages (including covering pages).
Transcript of hearing held at Ottawa on 10-SEP-2020 filed on 10-SEP-2020 Sent directly to presiding Judge 141 pages (including covering pages).
Transcript of hearing held at Ottawa on 09-SEP-2020 filed on 09-SEP-2020 Sent directly to presiding Judge 277 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 8-SEP-2020 filed on 08-SEP-2020 Sent directly to presiding Judge 108 pages (including covering pages).
Transcript of hearing held at Ottawa on 08-SEP-2020 filed on 08-SEP-2020 Sent directly to presiding Judge 19 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 4-SEP-2020 filed on 04-SEP-2020 Sent directly to presiding Judge 121 pages (including covering pages).
Transcript of hearing held at Ottawa on 04-SEP-2020 filed on 04-SEP-2020 Sent directly to presiding Judge 13 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 3-SEP-2020 filed on 03-SEP-2020 Sent directly to presiding Judge 32 pages (including covering pages).
Transcript of hearing held at Ottawa on 03-SEP-2020 filed on 03-SEP-2020 Sent directly to presiding Judge 16 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 2-SEP-2020 filed on 02-SEP-2020 Sent directly to presiding Judge 54 pages (including covering pages).
Transcript of hearing held at Ottawa on 02-SEP-2020 filed on 02-SEP-2020 Sent directly to presiding Judge 11 pages (including covering pages).
Transcript of hearing held In Camera at Ottawa on 01-SEP-2020 filed on 01-SEP-2020 Sent directly to presiding Judge 76 pages (including covering pages).
Transcript of hearing held at Ottawa on 01-SEP-2020 filed on 01-SEP-2020 Sent directly to presiding Judge 16 pages (including covering pages).
Ottawa 01-SEP-2020 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial in this action Result of Hearing: T-1960-18 discontinued September 1, 2020, Court allows Apotex to file the Second Reply Report of Dr. Taft September 2, 2020, Court allows that the Defendant's counsel for T-435-19 and T-806-19 can attend Bayer's confidential information September 10, 2020, Bayer's motion dated September 8, 2020 is denied without costs September 14, 2020, Dr. Moreton's evidence will be part of the record held by way of video conference Duration per day: 01-SEP-2020 from 09:37 to 17:03 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 02-SEP-2020 from 09:30 to 18:16 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 03-SEP-2020 from 09:30 to 17:00 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 04-SEP-2020 from 09:29 to 17:22 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 08-SEP-2020 from 09:30 to 17:36 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 09-SEP-2020 from 09:30 to 17:51 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 10-SEP-2020 from 09:15 to 16:59 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde 11-SEP-2020 from 09:30 to 15:30 Courtroom : Judge's Chambers (VC) Court Registrar: Kimberly Lalonde Total Duration: 8d Appearances: Christopher Van Barr, Melissa Binns, Alex Gloor, William Boyer 613-233-1781 representing Plaintiff Benjamin Pearson, Nathalia Thawe, Wiliam Foster, Mackenzie Jamieson 613-233-1781 representing Plaintiff Bradley White, Faylene Lunn, Lillian Wallace, Nathaniel Lipkus, Yael Mansour 613-235-7234 representing Defendant, T-1960-18 Harry Radomski, Daniel Cappe, Carl Scott, Sandon Shogilev 416-979-2211 representing Defendant, T-2093-18 Exhibits filed at hearing: 1-71 Witness(es) on behalf of Defendant, Teva Dr. Leslie Benet San Francisco, California on behalf of Defendant, Teva Dr. Alan Parr Cary, North Caroline on behalf of Defendant, Apotex Dr. David Taft Fair Haven, New Jersey on behalf of Defendant, Apotex Dr. Rebecca Betensky Lennox, Massachussets on behalf of Defendant, Teva Dr. Christian Moreton Waltham, Massachusetts on behalf of Defendant, Teva Dr. Jonathan Steed Durham, UK on behalf of Plaintiff Ms. Venessa Cocuzzoli Woodridge, Ontario on behalf of Plaintiff Mr. Dieter Zimmer Holirein, Switzerland on behalf of Plaintiff Dr. Paul Van Giersbergen Wuenheim, France on behalf of Plaintiff Inés de Lannoy Toronto, Ontario on behalf of Plaintiff Danille Dunn Guelph, Ontario on behalf of Plaintiff Justin Shefchek Windsor, Wisconsin on behalf of Plaintiff Miyah Smith Addison, Texas on behalf of Plaintiff Dr. Klaus Benke Bergisch Gladbach, Germany on behalf of Plaintiff Dr. Martyn Davies Nottinghamshire, UK on behalf of Plaintiff Dr. Aeri Park Indiana, USA on behalf of Plaintiff Dr. Linda Felton Albuquerque, New Mexico on behalf of Plaintiff Dr. Michael Eldon Emerald Hills, California on behalf of Plaintiff Dr. Ronald Thisted Chicago, Illinois on behalf of Plaintiff Birgit Keil Wuppertal, Aprather Weg 18a on behalf of Plaintiff Dr. Radu Pop Richmond Hill, ON Court Reporter: Mitchell Kersys 613-748-6043 01-SEP-2020 Mathieu Bastien-Marcil 613-748-6043 04-SEP-2020 Mitchell Kersys 613-748-6043 08-SEP-2020 Transcript requested (on an expedited basis) Sim. Translation: Almute Löber, Kerstin Jackish and Martina Köhler Comments: Heard with T-2093-18, Notice of Discontinuance filed on September 16, 2020 in present matter Minutes of Hearing entered in Vol. 1050 page(s) 1 - 17 Abstract of Hearing placed on file
Discontinuance on behalf of the Plaintiffs (Bayer Inc. and Bayer Intellectual Property GMBH) with consent on behalf of the Defendant (Teva Canada Ltd) filed on 16-SEP-2020
Solicitor's certificate of service on behalf of Will Boyer confirming service of Plaintiffs' Motion Record for Admissions of Documents upon Defendant by email on 06-SEP-2020 filed on 08-SEP-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 08-SEP-2020 Sent directly to Presiding Judge
Motion Record containing the following original document(s): 148 149 150 Number of copies received: 1 on behalf of Plaintiff (Confidential) filed on 08-SEP-2020
Written Confidential Submissions contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 148 filed on 08-SEP-2020
Affidavit of Susan Burkhardt sworn on 06-SEP-2020 contained within a Motion Record on behalf of Plaintiff (Confidential) in support of Motion Doc. No. 148 with Exhibits A filed on 08-SEP-2020
Confidential Notice of Motion contained within a Motion Record on behalf of Plaintiff in writing to be placed before the Court in Ottawa for Admission of Documents filed on 08-SEP-2020
Confidentiality Order dated 02-SEP-2020 rendered by The Honourable Mr. Justice Pentney Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 01-SEP-2020 re: enclosing draft orders Result: granted "THIS COURT ORDERS that: 1. Pursuant to Rule 151 of the Federal Courts Rules, for any document(s) which has been or at the trial of this action will be designated as Confidential Information pursuant to the Protective Agreements dated March 11, 2019 (T-1960-18) and March 28, 2019 (T-2093-18) in this proceeding, the parties are permitted to file or otherwise submit such document(s) under seal and such document(s) shall remain confidential and under seal until such time as this Court may otherwise Order or Direct. 2. Pursuant to Rule 151 of the Federal Courts Rules, any transcripts or recording of the trial proceedings pertaining to any confidential information, including documents designated as Confidential Information pursuant to point 1 above, shall remain confidential and under seal until such time as this Court may otherwise Order or Direct." Filed on 02-SEP-2020 copies sent to parties entered in J. & O. Book, volume 1462 page(s) 302 - 303 Interlocutory Decision
Letter from Plaintiff dated 01-SEP-2020 enclosing a second revised expert report of Dr. Byrn received on 01-SEP-2020
Order dated 01-SEP-2020 rendered by The Honourable Mr. Justice Pentney Matter considered without personal appearance The Court's decision is with regard to Letter from the parties re informal request for exclusion order dated 01-SEP-2020 Result: THE COURT ORDERS THAT: 1. All the fact witnesses who may testifiy in this action shall be excluded from the Courtroom until they have completed their testimony. 2. (...) See complete order Filed on 01-SEP-2020 copies sent to parties entered in J. & O. Book, volume 1462 page(s) 261 - 262 Interlocutory Decision
Letter from Defendant dated 31-AUG-2020 enclosing a USB key in accordance with the Protocol for electronic documents for the common trial T-1960-18 and T-2093-18 (e-trial toolkit) received on 31-AUG-2020
Draft Order concerning Witness exclusion for T-1960-18 and T-2093-18 consented to by all parties received on 01-SEP-2020
Draft Order concerning Confidentiality for T-1960-18 and T-2093-18 consented to by all parties received on 01-SEP-2020
Letter from Plaintiff dated 28-AUG-2020 enclosing reply expert reports of Andrew Gilkison and Dr. James Kaduk received on 28-AUG-2020
Letter from Defendant dated 26-AUG-2020 enclosing a USB key in accordance with the Protocol for electronic documents for the common trial T-1960-18 and T-2093-18 (e-trial toolkit) received on 26-AUG-2020
Letter from Defendant dated 24-AUG-2020 enclosing a USB key in accordance with the Protocol for electronic documents for the common trial T-1960-18 and T-2093-18 (e-trial toolkit) received on 24-AUG-2020
Copy of Reasons for Order and Order dated 28-AUG-2020 rendered by The Honourable Mr. Justice Pentney placed on file. Original filed on Court File No. T-2093-18
Letter from Defendant, Apotex (T-2093-18) on consent of all parties dated 28-AUG-2020 enclosing the trial calendar for the trial of common issues in T-1960-18 and T-2093-18 and informs the Court of a disagreement between the parties -scanned to the Court- received on 28-AUG-2020
Trial Calendar for T-1960-18 & T-2093-18 (Common Issues) from September 1 to 17, 2020 received on 28-AUG-2020
Solicitor's certificate of service on behalf of Will Boyer confirming service of Trial Record upon Defendant by email on 25-AUG-2020 filed on 25-AUG-2020
Trial Record on behalf of Plaintiff filed on 25-AUG-2020
Consent on behalf of all parties to the service and filing of the Amended Statement of Claim (25-AUG-2020) with proof of service upon all parties on 26-AUG-2020 filed on 27-AUG-2020
Solicitor's certificate of service on behalf of Melissa Binns confirming service of Doc no. 141 upon Plaintiff by electronic mail on 25-AUG-2020 filed on 25-AUG-2020
Amended Statement of Claim with consent of Defendant with proof of service upon Defendant on 26-AUG-2020 filed on 25-AUG-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 25-AUG-2020 directing that "In view of the parties' agreement set out in the letter dated August 24, 2020, the Court grants leave to the parties to file their expert reports in accordance with the terms set out in the letter. To be precise, the parties are granted leave to file reply expert reports except for the Teva motion to file reply expert reports in respect of the 204 testing. That matter will be dealt with separately." placed on file on 25-AUG-2020 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Alexander Camenzind confirming service of Plaintiff's responding motion record (DOCS. 137-139) upon Defendant by email on 24-AUG-2020 filed on 24-AUG-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 24-AUG-2020 Sent directly to Presiding Judge
Motion Record in response to Motion Doc. No. 132 containing the following original document(s): 137 138 Number of copies received: 1 on behalf of Plaintiff, CONFIDENTIAL filed on 24-AUG-2020
Written CONFIDENTIAL Representations contained within a Motion Record on behalf of Plaintiff concerning in opposition to Motion Doc. 132 filed on 24-AUG-2020
Affidavit of Susan Burkhardt sworn on 24-AUG-2020 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 132 with Exhibits A-G filed on 24-AUG-2020
Letter from Defendant dated 24-AUG-2020 to inform the Court that the Plaintiffs' motion records to file reply evidence (DOCS. 128-130 in T-1960-18 and DOCS.122-124 in T-2093-18) and the Defendant's Joint motion record to file reply evidence (DOCS. 126-129 in T-2093-18) have been resolved and request leave of the Court to file reply expert reports -scanned to the Trial Judge- received on 24-AUG-2020
Joint Claims Construction Chart (with file T-2093-18) received on 19-AUG-2020
Covering letter from Defendant dated 17-AUG-2020 concerning Confidential Motion Record (doc. no. 135), Book of Authorities (ID: 360) and Solicitor's Certificate of Service (doc. no. 136) placed on file on 17-AUG-2020
Solicitor's certificate of service on behalf of Lilian Wallace confirming service of the Defendant's Motion Record (for leave to file reply expert evidence) and Book of Authorities upon Plaintiffs by e-mail (with consent) on 17-AUG-2020 filed on 17-AUG-2020
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 17-AUG-2020
Motion Record containing the following original document(s): 132 133 134 Number of copies received: 1 on behalf of Defendant (contains CONFIDENTIAL documents) filed on 17-AUG-2020
Written Representations (CONFIDENTIAL) contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 132 filed on 17-AUG-2020
Affidavit of Daniel Wright sworn on 17-AUG-2020 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 132 with Exhibits "A" to "E" filed on 17-AUG-2020
Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for an Order granting Teva leave to serve and file the Reply Expert Reports of Dr. Leslie Z. Benet and Dr. Richard Christian Moreton filed on 17-AUG-2020
Solicitor's certificate of service on behalf of Will Boyer confirming service of the Plaintiffs' Motion Record and Book of Authorities upon Defendant by e-mail (notice of consent to electronic service dated November 19, 2018) on 17-AUG-2020 filed on 17-AUG-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 17-AUG-2020
Motion Record containing the following original document(s): 128 129 Number of copies received: 1 on behalf of Plaintiffs (CONFIDENTIAL MOTION RECORD) filed on 17-AUG-2020
Written Representations (CONFIDENTIAL) contained within a Motion Record on behalf of Plaintiffs concerning Motion Doc. No. 128 filed on 17-AUG-2020
Notice of Motion contained within a Motion Record on behalf of Plaintiffs returnable (but no hearing date indicated at this time) for leave to file the reply expert reports of Dr. Gilkison and Dr. Kaduk filed on 17-AUG-2020
Solicitor's certificate of service on behalf of Lillian Wallace confirming service of the Confidential Affidavit of Dr. Mathivanan upon Plaintiffs by electronic mail on 10-AUG-2020 filed on 10-AUG-2020
Letter from Defendant dated 10-AUG-2020 enclosing the Confidential Affidavit of Dr. Mathivanan for use at trial received on 10-AUG-2020
Solicitor's certificate of service on behalf of Will Boyer confirming service of the Confidential Willsay Statement of Birgit Keil upon Defendant by e-mail (notice of consent to electronic service dated November 19, 2019) on 10-AUG-2020 filed on 10-AUG-2020
Letter from Plaintiffs dated 10-AUG-2020 advising of their intention to submit an affidavit of Birgit Keil but noting that they were unable to provide a sworn affidavit from her today. As such, they enclose the will say statement of Ms. Keil which has been served on the Defendants. received on 10-AUG-2020
Letter from Plaintiffs dated 10-AUG-2020 enclosing the Confidential Affidavit of Dr. Aeri Park sworn August 7, 2020 in connection with the infringement portion of the trial received on 10-AUG-2020
Solicitor's certificate of service on behalf of Will Boyer confirming service of the Plaintiffs' fact affdavits for use at trial upon Defendant by e-mail (Notice of Consent to Electronic Service dated 19-NOV-2018) on 10-AUG-2020 filed on 10-AUG-2020
Letter from Plaintiffs dated 10-AUG-2020 enclosing the following fact affidavits on behalf of the plaintiffs in connection with the common patent validity portion of the trial: 1. Confidential Affidavit of Dr. Aeri Park sworn August 7, 2020; 2. Confidential Affidavit Danille Dunn sworn July 31, 2020; 3. Confidential Affidavit of Inés De Lannoy sworn August 5, 2020; 4. Confidential Affidavit of Dr. Anita Kress sworn on August 6, 2020; 5. Confidential Affidavit of Dr. Dieter Zimmer sworn on July 31, 2020; 6. Confidential Affidavit of Dr. Klaus Benke sworn August 3, 2020; 7. Confidential Affidavit of Dr. Manisha Saxena sworn August 6, 2020; 8. Confidential Affidavit of Dr. Paul van Giersbergen sworn August 5, 2020; 9. Confidential Affidavit of Justin Shefchek sworn August 6, 2020; 10. Confidential Affidavit of Miyah Smith sworn August 5, 2020; 11. Confidential Affidavit of Svenja Krupp sworn August 6, 2020; 12. Confidential Affidavit of Veronica Tsou sworn August 6, 2020; 13. Confidential Affidavit of Christoph Siethoff sworn August 5, 2020; and 14. Confidential Affidavit of Vanessa Cocuzzoli sworn August 10, 2020. Counsel also advises of their intention to file an affidavit from Birgit Keil, but notes they are unable to provide a sworn affidavit at this time and will therefore be serving a will say statement. received on 10-AUG-2020
Ottawa 13-AUG-2020 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial Management Conference Result of Hearing: Current Scheduling Order was amended to reflect that the trial calendars are to be provided on or before August 21, 2020. Plaintiffs will be filing a motion for leave to file late, unredacted expert reports sometime early next week. held by way of ZOOM video conference Duration per day: 13-AUG-2020 from 02:00 to 03:48 Courtroom : Not Applicable Court Registrar: Emily Price Total Duration: 1h48min Appearances: Mr.Van Barr, Ms.Binns, Mr.Boyer, Mr.Gloor, Mr.Pearson, Ms.Thawe 613-786-8675 representing Plaintiffs Mr. White, Ms. Lunn, Ms. Wallace, Ms. Mansour 613-787-1101 representing Defendant Minutes of Hearing entered in Vol. 1048 page(s) 127 - 130 Abstract of Hearing placed on file
Letter from Defendant dated 07-AUG-2020 advising the Court of the expert reports being provided through secure file transfer further to the last trial management conference. received on 07-AUG-2020
Letter from Plaintiff dated 07-AUG-2020 advising the Court of the confidential expert reports being provided (electronic copies of expert reports submitted through TitanFile transfer) received on 07-AUG-2020
Letter from Plaintiffs dated 10-AUG-2020 advising that the parties have come to an agreement concering the confidentiality motion and that the hearing scheduled for August 12, 2020 is no longer required (scanned directly to Trial Judge) received on 10-AUG-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 07-AUG-2020
Motion Record containing the following original document(s): 121 122 123 Number of copies received: 1 on behalf of Plainitff (containing CONFIDENTIAL information) filed on 07-AUG-2020
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 121 filed on 07-AUG-2020
Affidavit of Vanessa Lessard (CONFIDENTIAL EXHIBITS) sworn on 07-AUG-2020 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 121 with Exhibits "A" to "MM" filed on 07-AUG-2020
Notice of Motion contained within a Motion Record on behalf of Plaintiffs returnable at Special Sitting in Ottawa on 12-AUG-2020 to begin at 09:30 for "1. an order that Teva documents 13.1-13.10 and Items 7 (R2) - K-49062 and 9 (R2) - K-49111 (the "Teva Documents") do not contain confidential information of the defendant ("Teva"); or, in the alternative, 2. An order, pursuant to paragraph 30 of the parties' Protective Agreement, granting Bayer leave of this Court to disclose the Teva Documents and the information contained therein to Apotex Inc. ("Apotex") in the companion litigation T-2093-18, with any disclosure of the Teva Documents or information contained therein limited to Apotex's external counsel, expert witnesses, and other personal who are required to view this information for the purpose of T-2093-18; and 3. An order granting Bayer leave of this Court from the implied undertaking in respect of the Teva Documents for use in this companion litigation of T-2093-18; 4. Costs of this motion; and 5. Such further and other relief as this Honourable Court may deem just." filed on 07-AUG-2020
Writ of Subpoena Ad Testificandum issued on 07-AUG-2020 cc filed
Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 07-AUG-2020 Tariff any other proceeding - $30.00
Writ of Subpoena Ad Testificandum issued on 06-AUG-2020 cc filed
Request for Writ(s) of Subpaena Ad Testificandum (x5) on behalf of Plaintiff filed on 06-AUG-2020 Tariff any other proceeding - $30.00
Letter from Plaintiffs dated 06-AUG-2020 pursuant to the oral direction of the Court (Pentney, J.) dated August 4, 2020 asking parties to provide their position to the Court as to whether Apotex should be given notice of, and an opportunity to participate in, the pending confidentiality motion. (scanned directly to Trial Judge and CMJ) received on 06-AUG-2020
Letter from Defendant dated 06-AUG-2020 in accordance with the oral direction of the Court (Pentney, J.) dated August 4, 2020 whereby parties were to provide their position to the Court as to whether the Defendant Apotex should be given notice of this proceeding and an opportunity to participate. (scanned directly to Trial Judge and CMJ) received on 06-AUG-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions of the Court (Pentney, J.) dated 04-AUG-2020 (ID: 327) placed on file on 04-AUG-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 04-AUG-2020 directing that "1. The Plaintiff's motion regarding confidentiality of certain Teva documents shall be heard, by Zoom, on Tuesday, August 12, 2020 at 9:30 a.m. for a duration of not more than two hours. 2. Plaintiff's motion record shall be filed and served by 3:00 p.m. on Friday, August 7, 2020. 3. Defendant Teva¿s motion record shall be filed and served by 3:00 pm on Monday, August 10, 2020. 4. On or before 3:00 pm on Thursday, August 6, 2020, the parties are to provide their position to the Court as to whether the Defendant Apotex should be given notice of this proceeding, and an opportunity to participate." placed on file on 04-AUG-2020 Confirmed in writing to the party(ies)
Letter from Plaintiffs dated 04-AUG-2020 in response to the Defendant's letter dated July 31, 2020. (scanned directly to Trial Judge and CMJ) received on 04-AUG-2020
Letter from Defendant dated 31-JUL-2020 in response to the Plaintiff's letter dated 30-JUL-2020 requesting an urgent motion hearing (scanned directly to Trial Judge and CMJ) received on 31-JUL-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions ID: 323 placed on file on 30-JUL-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 30-JUL-2020 directing that "A trial managament video conference will be held by Zoom from 2:00 p.m. to 3:30 p.m. on August 13, 2020." placed on file on 30-JUL-2020 Confirmed in writing to the party(ies)
Letter from Plaintiffs' counsel dated 30-JUL-2020 requesting an urgent motion to resolve a matter of confidentiality relating to documents produced by the Defendant in this proceeding. (scanned directly to Trial Judge and CMJ) received on 30-JUL-2020
Letter from Defendant's counsel dated 27-JUL-2020 providing dates of mutual dates of availability for a trial management/case management conference during the weeks of August 3 and 10. (scanned directly to Trial Judge and CMJ) received on 27-JUL-2020
Acknowledgment of Receipt received from both parties (by e-mail) with respect to oral directions dated 14-JUL-2020 (ID: 319) placed on file on 14-JUL-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 14-JUL-2020 directing that "Further to the joint Case Management\Trial Management conference on Monday, July 13, 2020, and to the discussion of a session to demonstrate how a virtual trial conducted using the Zoom platform will operate, the Court directs: 1. The parties are to consult and to provide mutual availabilities during the weeks of August 3 and 10 for a CMC/TMC of no more than 1.5 hours. The main purpose of this CMC/TMC is to demonstrate the way in which a virtual virtual trial using the Zoom platform will proceed. The parties are to consult on any other agenda items they wish to discuss during this session. 2. The parties are to identify likely members of their respective "teams" for the trial, and to provide email contact information for: a. Counsel and co-counsel b. Client representatives (who wish to participate in the "mock" Zoom hearing). 3. The parties are to explore the E-filing toolkit available on the Federal Federal Court website, and to identify any questions they have regarding it as the main document sharing platform for the electronic record for the trial. 4. The parties are asked to identify a document they wish to share with other parties and the Court - to demonstrate the document sharing and screen sharing functionalities (each counsel should have a short document to share, that can be emailed to all participants and then a page from that document can be shared during the session). 5. The parties are to identify and to provide to the Court, no later than 10 days prior to the next CMC/TMC, any other questions they wish to discuss to discuss (or functionalities they wish to explore) relating to a virtual trial held using the Zoom platform, so that the Court can provide further technical details or other information in order to address any other issues. In addition, if any of the counsel or parties want to observe an actual patent trial using the Zoom platform, they can contact the Judicial Administrator to request to be made an observer at the trial that is currently underway (T-113-18, Rovi Guides and Tivo Solutions v BCE and Bell Canada et al.)." placed on file on 14-JUL-2020 Confirmed in writing to the party(ies)
Ottawa 13-JUL-2020 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial Management Conference and Case Management Conference (Madam Prothonotary Tabib also presiding) Result of Hearing: experts reports to be provided to the Court on or about August 5, 2020. Direction to follow regarding the next joint cmc/tmc to be scheduled in the coming weeks. held by way of Zoom video conference Duration per day: 13-JUL-2020 from 09:30 to 10:25 Courtroom : Not Applicable Court Registrar: Emily Price Total Duration: 55 min Appearances: Mr. Christopher Van Barr, Ms. Melissa Binns, Mr. Will Boyer 613-786-8675 representing Plaintiffs Mr. J. Bradley White, Ms. Faylene Lunn, Ms. Lillian Wallace 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1046 page(s) 387 - 391 Abstract of Hearing placed on file
Letter from Plaintiffs dated 13-JUL-2020 further to the Court's direction of July 10, 2020, providing the Plaintiffs' proposed witness list (scanned directly to Trial Judge and CMJ) received on 13-JUL-2020
Letter from counsel for Apotex (writing on behalf of Teva as well) dated 13-JUL-2020 in response to the Court's Direction of July 10, 2020, and counsel to Bayer's letter of the same date. (scanned directly to Trial Judge and CMJ) received on 13-JUL-2020
Letter from Plaintiffs dated 10-JUL-2020 in response to oral direction ID: 313 requesting additional information from the parties in advance of the TMC/CMC scheduled for Monday at 9:30 a.m. (scanned directly to Trial Judge / CMJ) received on 10-JUL-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral direction dated 07-JUL-2020 (ID: 313) placed on file on 10-JUL-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 10-JUL-2020 directing that "Further to the Direction issued June 30, 2020, the Court has reviewed the correspondence from counsel for Apotex dated July 8, 2020, including the preliminary draft trial calendar for the trial of common issues proposed by Teva and Apotex. The information provided is not sufficient to enable the Court to meaningfully address the issues raised regarding the number of days currently allotted for the trial of common issues. The parties are to provide further information on or before 9:00 a.m. on Monday, July 13, 2020, including: - A preliminary list of witnesses; - An indication of why the allotted trial time is not sufficient to allow the witnesses' evidence to be provided (including whether there is any direct examination proposed for any of these witnesses) The parties are directed to consult, and if they cannot agree, then each party may provide its own response to this Direction." placed on file on 10-JUL-2020 Confirmed in writing to the party(ies)
Letter from D's counsel in T-2093-18 on behalf of all parties in T-2093-18 and T-1960-18 dated 08-JUL-2020 providing agenda items for hte joint cmc/tmc on July 13, 2020 and enclosing a draft trial schedule (scanned directly to Trial Judge and CMJ) received on 09-JUL-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions of the Court (Pentney, J.) dated 30-JUN-2020 (ID: 310) placed on file on 30-JUN-2020
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 30-JUN-2020 directing that "In light of the parties¿ correspondence concerning the length of the trial of common issues, a Case Management/Trial Management Conference will be held on Monday, July 13, 2020, commencing at 9:30 for a duration of up to 1.5 hours. The parties are to provide a proposed preliminary draft trial schedule for the trial of common issues on or before Wednesday July 8, 2020. In addition, if the parties wish to deal with any matters other than trial length, they must consult and provide a joint proposal for other agenda items on or before Wednesday July 8, 2020." placed on file on 30-JUN-2020 Confirmed in writing to the party(ies)
Letter from Defendant's counsel in T-2093-18 on behalf of Teva's counsel as well dated 29-JUN-2020 in response to the Plaintiffs' letter dated JUne 23, 2020 (scanned directly to Trial Judge and CMJ) received on 26-JUN-2020
Letter from Plaintiffs dated 24-JUN-2020 regarding changes to the trial schedule (scanned directly to Trial Judge) received on 24-JUN-2020
Copy of Reasons for Judgment and Judgment dated 14-MAY-2020 rendered by The Honourable Mr. Justice Nadon The Honourable Mr. Justice Pelletier The Honourable Mr. Justice de Montigny placed on file. Original filed on Court File No. A-389-19
Letter from Defendant dated 18-JUN-2020 in response to the Plaintiffs' letter dated June 11, 2020 (ID: 305)re trial dates (scanned directly to Trial Judge) received on 18-JUN-2020
Letter from Plaintiffs dated 11-JUN-2020 re changes to the trial schedule proposed by Teva and Apotex at the trial management conference on June 1, 2020 (scanned directly to Trial Judge) received on 12-JUN-2020
Acknowledgment of Receipt received from both parties (by e-mail) with respect to Order doc. no. 116 placed on file on 09-JUN-2020
Order dated 09-JUN-2020 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiffs dated 08_JUN-2020 enclosing draft scheduling order ID: 301 dated 09-JUN-2020 Result: "THIS COURT ORDERS that: 1. The parties shall exchange fact witness lists by July 31, 2020; 2. The parties shall exchange proposed expert qualification by August 6, 2020; 3. The deadline for parties to serve notices to admit facts is August 7, 2020; 4. Affidavits of fact evidence-in-chief for use at trial shall be served and filed by August 10, 2020, however service and filing of an affidavit is not an undertaking that the affidavit will be tendered as evidence at at trial and, for affidavits that are tendered as evidence at trial, any affiant providing viva voce evidence at trial is permitted to explain evidence contained in the affidavit provided the matter is addressed in the affidavit; 5. The parties shall exchange read-ins by August 12, 2020; 6. Any objections to any in-chief or responding expert report, including to expert qualifications, shall be served by August 14, 2020; 7. The parties shall file trial calendars by August 18, 2020; 8. The parties shall file a joint claims construction chart by August 19, 2020; 9. The parties shall serve responses to notices to admit facts by the earlier of 20 days after service of the notice or August 21, 2020; 10. The parties shall serve any demonstrative evidence (any presentation aid not found precisely in an expert report) by August 10, 2020; 11. The parties shall exchange responsive read-ins by August 26, 2020; and 12. The parties shall serve any objection to demonstrative evidence by August 17, 2020; and 13. Once the in-chief expert reports have been filed, the parties will will prepare a scientific primer, only if requested by the Court. The filing of an expert report is not an undertaking that the expert will be tendered at trial." Filed on 09-JUN-2020 copies sent to parties entered in J. & O. Book, volume 1455 page(s) 150 - 152 Interlocutory Decision
Letter from Plaintiffs dated 08-JUN-2020 re affidavits to be filed and enclosed draft scheduling order (scanned directly to Trial Judge and CMJ) received on 08-JUN-2020
Draft Order concerning draft scheduling orders received on 08-JUN-2020
Ottawa 03-JUN-2020 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial Management Conference and Case Management Conference. Madam Prothonotary Tabib also presiding. Result of Hearing: Plaintiffs to submit a letter to the Court regarding evidence to be presented at trial by June 8, 2020; Defendant's response to be submitted by June 15, 2020; Plainitffs' reply by noon on June 17, 2020. held by way of Zoom videoconference Duration per day: 01-JUN-2020 from 02:03 to 03:52 Courtroom : Not Applicable Court Registrar: Emily Price Total Duration: 1h49min Appearances: Mr. Christopher Van Barr / Ms. Melissa Binns / Mr. Will Boyer 613-786-8675 representing Plaintiffs Mr. J. Bradley White / Ms. Faylene Lunn / Ms. Lillian Wallace 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1045 page(s) 58 - 65 Abstract of Hearing placed on file
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 115 placed on file on 23-MAY-2020
Order dated 22-MAY-2020 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff (jointly on behalf of the Defendant) dated 22-MAY-2020 re: enclosed draft scheduling order Result: "THIS COURT ORDERS that: 1. The Plaintiffs shall deliver their answers arising from the May 11, 2020 Order by May 15, 2020; 2. Expert reports in chief on infringement and invalidity shall be served by May 22, 2020; 3. Responding expert reports shall be served by August 5, 2020; 4. Any proposed reply reports and motions for leave to file reply expert reports shall be served by August 17, 2020 and any responding materials shall be served by August 24, 2020; 5. The parties will work together in good faith to resolve the remainder of the schedule, and provide a proposed schedule at or before the joint case/trial management video conference scheduled to be held at 2 pm on June 1, 2020." Filed on 22-MAY-2020 copies sent to parties entered in J. & O. Book, volume 1454 page(s) 131 - 132 Interlocutory Decision
Acknowledgment of Receipt received from both parties (by e-mail) with respect to oral directions ID: 296 placed on file on 22-MAY-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 22-MAY-2020 directing that "A joint case/trial management video conference will be held by Zoom at 2 pm on June 1, 2020. The parties are to provide a proposed agenda to the Court by May 29, 2020." placed on file on 22-MAY-2020
Letter from Plaintiff (on behalf of defendant as well) dated 21-MAY-2020 enclosing draft scheduling orders and advising of mutual dates of availability for a case management conference (scanned directly to CMJ: Tabib, P.) received on 22-MAY-2020
Draft Order concerning draft scheduling order received on 22-MAY-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions ID: 292 placed on file on 11-MAY-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 11-MAY-2020 directing that "As the final motion for refusals has now been determined, the exact schedule pursuant to which the remaining steps in this action are to be completed can be ascertained. The Court would appreciate the parties consulting and providing it with draft amended orders setting out the final timelines within the next few weeks, on the understanding that the parties will govern themselves in accordance with the proposal set out in counsel's letter of May 7, 2020. The Court is also looking to hold a joint case/trial management conference by Zoom in late May or early June to address the following matters: 1. Any remaining scheduling issues. 2. Whether the parties foresee any issues with proceeding on the scheduled dates, in light of the uncertainty about travel and other restrictions. 3. Whether the parties have any objection to proceeding with a virtual hearing, if that is necessary in light of public health restrictions. 4. Modalities and timing for a scientific primer for the Trial Judge. 5. Any other issue the parties may raise. The parties are therefore asked to consult with each other and provide their mutual dates of availability for this joint conference at their earliest convenience. The parties will also be required to provide the Court with a proposed agenda at least two days before the joint conference." placed on file on 11-MAY-2020 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from both parties (by e-mail) with respect to Order doc. no. 114 placed on file on 11-MAY-2020
Order dated 11-MAY-2020 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 104 Result: "THIS COURT ORDERS that: 1. Subject to the qualifications and comments set out in the body of this order, the Plaintiffs are to answer the following questions: a. From Schedule ¿A¿: Items 5, 6, 62, 63, 64, 73, 75, 76, 77, 84, 85, 88, 104, 141, 142 and 145; b. From Schedule ¿B¿: Items 2, 58, 83, 85, 86, 91, 92, 93, 95, 100, 101, 103, 105, 106, 111, 112 (first 2 portions), 115, 121, 122 to 125 (only if studies were conducted but no documents produced), 126, 127, 155 to 158, 159, 166 to 169, 183 to 194 (to the extent they predate the filing date), 195, 270, 281, 282 (data only), 285 and 293; 2. Unless either or both parties serve and file, within 10 days of this Order, submissions as to a different award of costs, there shall be no costs on this motion. 3. A party may serve and file responding submissions within 7 days of the service of an opposing party's submissions on costs in accordance with paragraph 2." Filed on 11-MAY-2020 copies sent to parties entered in J. & O. Book, volume 1453 page(s) 242 - 243 Interlocutory Decision
Letter from Plaintiffs (on consent of all parties) dated 07-MAY-2020 providing a proposed schedule for exchange of expert reports (scanned directly to CMJ: Tabib, P.) received on 08-MAY-2020
Covering letter from Defendant dated 03-APR-2020 concerning Motion material (Apotex's and Teva's motion to compel) placed on file on 03-APR-2020
Solicitor's certificate of service on behalf of Lilian Wallace confirming service of Motion Record (doc. 108), Joint Book of Documents (doc. 112), Book of Authorities (ID: 286) upon Plaintiffs by e-mail on 03-APR-2020 filed on 03-APR-2020
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 03-APR-2020
Joint Book of Documents (re motion doc. no. 105) consisting of 2 volume(s) prepared by Defendant filed on 03-APR-2020 1 judges' copies sent directly to CMJ: Tabib, P.
Sealed envelope pursuant to direction of the Court dated January 8, 2020 on behalf of Defendant purporting to contain Transcript doc. no. 110 (for the purpose of motion doc. no. 104) Filed on 03-APR-2020
Transcript of CONFIDENTIAL RE: Examination of Discovery of CONFIDENTIAL held on February 12, 2020 filed on 03-APR-2020
Sealed envelope pursuant to direction of the COurt dated January 8, 2020 on behalf of Defendant purporting to contain motion record doc. no. 108 Filed on 03-APR-2020
Motion Record containing the following original document(s): 105 106 107 Number of copies received: 1 on behalf of Defendant filed on 03-APR-2020
Refusals Chart (CONFIDENTIAL) - Moving, Responding and Reply Submissions and Positions Chart regarding inter partes testing conducted in T-1960-18 and T-2093-18 - re motion doc. no. 101 (Schedule C) filed on 03-APR-2020
Refusals Chart (CONFIDENTIAL) - Moving, Responding and Reply Submissions and Positions Chart regarding CA 2,823,159 - re motion doc. no. 101 (Schedule B) filed on 03-APR-2020
Refusals Chart (CONFIDENTIAL) - Moving, Responding and Reply Submissions and Positions Chart regarding CA 2,547,113 (Schedule A) contained within Motion Record on behalf of the Defendant - re motion doc. no. 101 filed on 03-APR-2020
Notice of Motion contained within a Motion Record on behalf of Defendant in writing to be placed before the Court in Ottawa for an Order "1. An order directing that the Plaintiffs provide answers to the questions from its examinations for discovery as set out in the position charts at Schedules "A", "B", and "C" delivered under separate cover to the Court. 2. Costs of these motions; and 3. Such further and other relief as this Honourable Court may deem just." filed on 03-APR-2020
Copy of Reasons for Judgment and Judgment dated 08-APR-2020 rendered by The Honourable Mr. Justice de Montigny The Honourable Madam Justice Woods The Honourable Mr. Justice Laskin placed on file. Original filed on Court File No. A-15-20
Letter from Plaintiff dated 03-APR-2020 Encl. BOA and inform the Court that the Defendant will file a single joint book of documents and charts re motion to compel received on 03-APR-2020
Solicitor's certificate of service on behalf of William S. Foster confirming service of Book of Authorities of the Plaintiffs upon all parties by email on 03-APR-2020 filed on 03-APR-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 03-APR-2020 Sent directly to Presiding Judge
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 102 placed on file on 07-APR-2020
Order dated 06-APR-2020 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 95 Result: "THIS COURT ORDERS that: 1. The Plaintiffs are to answer Questions 1 and 2. 2. The Plaintiffs shall answer Question 10 to the extent they have responsive information, knowledge or belief other than their own own interpretation of the test results. 3. The Defendant's motion is otherwise dismissed, without costs." Filed on 06-APR-2020 copies sent to parties entered in J. & O. Book, volume 1451 page(s) 162 - 163 Interlocutory Decision
Covering letter from Defendant dated 03-APR-2020 concerning Doc. Nos. 97 99 101 placed on file on 03-APR-2020
Solicitor's certificate of service on behalf of Lillian Wallace confirming service of doc. no. 97 (Motion Record) and doc. no. 99 (Book of Documents) upon Plaintiffs by electronic mail on 03-APR-2020 filed on 03-APR-2020
Book of Documents (CONFIDENTIAL) consisting of 1 volume(s) including confidential volume(s) 1 prepared by the Defendant (re Defendant's motion to compel doc. no. 95) filed on 03-APR-2020 1 judges' copies stored in Ottawa
PUBLIC VERSION of Defendant's Motion Record doc. no. 97 filed on 03-APR-2020
Sealed envelope pursuant to direction dated 08-JAN-2020 / Protective Agreement dated 11-MAR-2019 on behalf of Defendant purporting to contain 97 Filed on 03-APR-2020
Motion Record containing the following original document(s): 95 96 Number of copies received: 1 on behalf of Defendant filed on 03-APR-2020
Refusals Chart (CONFIDENTIAL) on behalf of the Defendant re Refusals and under advisements from Teva's examiation for discovery of Bayer's corporate representative held on Febraury 12, 2020. (includes moving, responding and reply submissions) containing within Defendant's motion record filed on 03-APR-2020
Notice of Motion contained within a Motion Record on behalf of Defendant in writing to be placed before the Court in Ottawa for 1. An order directing that the Plaintiffs provide answers to the questions from its examination of discovery as set in the positions chart attached as Schedule "A" to this motion. 2. Teva's costs for this motion; and 3. Such further and other relief as this Honourable Court may deem just. filed on 03-APR-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 94 placed on file on 31-MAR-2020
Order dated 30-MAR-2020 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 82 Result: dismissed "THIS COURT ORDERS that: 1. The Plaintiffs' motion is dismissed, without costs." Filed on 30-MAR-2020 copies sent to parties entered in J. & O. Book, volume 1451 page(s) 30 - 32 Interlocutory Decision
Covering letter from Defendant dated 24-MAR-2020 concerning Motion Record doc. no. 91, BOA ID: 258, Solicior's Certificate of Service doc. no. 93 placed on file on 24-MAR-2020
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of Motion Record doc. no. 91 and Book of Authorities ID: 256 upon Plaintiffs by e-mail on 20-MAR-2020 filed on 24-MAR-2020
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 24-MAR-2020
Sealed envelope pursuant to direction of the Court dated 08-JAN-2020 on behalf of Defendant purporting to contain Motion Record doc. 91 Filed on 24-MAR-2020
Motion Record in response to Motion Doc. No. 82 containing the following original document(s): 89 Number of copies received: 1 on behalf of Defendant filed on 24-MAR-2020
Affidavit of Yael Mansour sworn on 20-MAR-2020 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 82 with Exhibits "A" filed on 24-MAR-2020
Refusals Chart (CONFIDENTIAL) contained within a Motion Record on behalf of the Defendant in response to Motion Doc. No. 82 filed on 24-MAR-2020
Covering letter from Plintiffs dated 13-MAR-2020 concerning Plaintiffs' Motion Record (doc. no. 85), BOA (ID: 251) and Solicitor's Certificate of Service (doc. no. 88) placed on file on 13-MAR-2020
Solicitor's certificate of service on behalf of William S. Foster confirming service of Plaintiffs' Motion Record (doc. no. 85) and BOA (ID: 251) upon Defendant by e-mail on 13-MAR-2020 filed on 13-MAR-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiffs received on 13-MAR-2020
Sealed envelope pursuant to Protective Agreement dated March 11, 2019 on behalf of Plaintiffs purporting to contain volume 3 of Plaintiff's Motion Record doc. no. 85 Filed on 13-MAR-2020
Sealed envelope pursuant to Protective Agreement dated March 11, 2019 on behalf of Plaintiffs purporting to contain volume 2 of Plaintiff's Motion Record doc. no. 85 Filed on 13-MAR-2020
Motion Record containing the following original document(s): 82 83 84 Number of copies received: 3 on behalf of Plaintiffs filed on 13-MAR-2020
Refusals Chart (CONFIDENTIAL) contained within a Motion Record on behalf of the Plaintiffs in support of Motion Doc. No. 82 filed on 13-MAR-2020
Affidavit of Susan Burkhardt sworn on 13-MAR-2020 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 82 with Exhibits "A" to "M" filed on 13-MAR-2020
Notice of Motion contained within a Motion Record on behalf of Plaintiffs in writing to be placed before the Court in Ottawa for 1. An Order: a. requiring Teva Canada Limited to ("Teva") to provide answers to refusals from the Continued Examination for Discovery of Dr. Mathi Mathivanan held March 6, 2020, that are relevant as set out in the Plaintiffs' Refusals Chart; b. granting the Plainitffs' costs of this motion; and 2. Such further and other relief as this Honourable Court may deem just. filed on 13-MAR-2020
Covering letter from the Plaintiffs (Bayer Inc & Bayer Intellectual Property GMBH) dated 27-MAR-2020 concerning Doc. Nos. 80 81 placed on file on 27-MAR-2020
Solicitor's certificate of service on behalf of Benjamin Pearson confirming service of document no. 80 upon the Defendant (Teva Canada Inc) by e-mail on 27-MAR-2020 filed on 27-MAR-2020
Reply Submissions on behalf of the Plaintiffs (Bayer Inc & Bayer Intellectual Property GMBH) in response to the opposing submissions doc. No. 74 to the Motion in writing Filed on 27-MAR-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 25-MAR-2020 directing that "The Court agrees with and thanks the parties for their very practical suggestion." placed on file on 25-MAR-2020 Confirmed in writing to the party(ies)
Letter from Defendant dated 25-MAR-2020 re Defendants' motions to compel (T-1960-18, T-2093-18, T-806-19, T-435-19) proposing on consent, that one set of position charts be filed with the Court by April 3, 2020 (scanned to CMJ: Tabib, P.) received on 25-MAR-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions ID: 238 placed on file on 24-MAR-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-MAR-2020 directing that "The Court approves the parties¿ proposal and schedule. The instructions and caveats set out in the Direction of March 20, 2020 will however also apply to that motion." placed on file on 24-MAR-2020 Confirmed in writing to the party(ies)
Letter from Plaintiffs (on consent of the Defendant) dated 24-MAR-2020 regarding a proposed scheduling for the serving/filing of the motion material (re Defendant's motion to compel) to be heard in writing (scanned to CMJ: Tabib, P.) received on 24-MAR-2020
Acknowledgment of Receipt received from all partis (by e-mail) with respect to oral directions ID: 235 placed on file on 20-MAR-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 20-MAR-2020 directing that "The Court is in principle amenable to the parties' suggested course of action, but may of course reassess in light of the materials, once received. The parties' reply submissions are to be presented as an additional column to the usual refusals charts. The parties should also realize that given the expected volume of questions to be ruled upon, rulings will likely be as brief as those typically rendered from the bench, but without the oral exchanges that tend to provide context for the rulings. The partis are asked to endeavour to file their materials electronically, wherever possible. In order to ease the strain on resources, duplications and unecessary documents should be avoided (for example, copies of patents and pleadings are not required; where documents or transcripts must be referred to, perhaps only include the relevant pages, and use condensed transcripts)." placed on file on 20-MAR-2020 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from all parties with respect to the Direction rendered on March 13, 2020 placed on file on 17-MAR-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 13-MAR-2020 directing that "The parties are to advise, as soon as possible, of the expected duration of the hearing, as measures related to the Corona virus pandemic may make hearing in person impossible during the month of March 2020. If so, the hearing may have to take place by telephone conference. placed on file on 17-MAR-2020
Communication to the Court from the Registry dated 12-MAR-2020 re: letter ID: 231
Letter from Defendant (with consent of counsel for Bayer, Apotex, Taro and Sandoz) dated 11-MAR-2020 "(...) On March 6, 2020, Teva and Apotex advised Bayer that they intend to bring motions to compel in respect of the continued examination of Bayer. Teva, Apotex and Bayer propose the following motions schedule, subject to the Court's availability (...)" received on 11-MAR-2020
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 79 and copy of Reasons ID: 229 placed on file on 04-MAR-2020
Copy of Reasons for Decision dated 03-MAR-2020 rendered by Mireille Tabib, Prothonotary concerning motions to compel heard January 9-10, 2020 placed on file. Original filed on Court File No. T-2093-18
Order dated 03-MAR-2020 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 65 Result: "THIS COURT ORDERS that: 1. Bayer will answer the following items: a. Teva's and Apotex's Moving Position Chart - Nowak Part I: 1, 2, 4, 5, 19, 92 (as clarified on page 78 of the transcript), 153, 154, 157, 161, 162, 167, 168, 169, 170, 171, 172, 173 (to the extent it is not apparent based on other documents provided in respect of BAYER 37, 38 and 41), 280, 301 and 302; b. Teva's and Apotex's Moving Position Chart - Nowak Part II: 27, 28, 29, 30, 31, 33, 70, 84, 85, 86, 127, 129, 130, 131, 135, 143, 144, 203, 206, 252, 255, 256, and 282; c. Teva's and Apotex's Moving Position Chart - Cocuzzoli: 56, 61, 64, 67, 69, 73 (clarify in light of the ruling on item 69), 91, 92, 93, 96 (to the extent it seeks to know whether the denial is factually based on Bayer's knowledge, information or belief as to what the tablets contained), 144, 162, 163, 166, 253 and 287; and d. Sandoz's Moving Position Chart - Nowak and Cocuzzoli: 2, 4, 5, 6, 7, 8, 12, 13, 23(ii), 24 and 25. 2. Item 244 of Nowak Part II (re: 159 Patent) is suspended. 3. Costs in the cause." Filed on 03-MAR-2020 copies sent to parties entered in J. & O. Book, volume 1449 page(s) 66 - 69 Interlocutory Decision
Acknowledgment of Receipt received from all parties (by e-mail) with respect to order doc. nos. 77 and 78 placed on file on 13-FEB-2020
Order dated 13-FEB-2020 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 72 Result: "THIS COURT ORDERS that: 1. Teva shall answer the following Questions, subject to the conditions set out in the preamble to this order: Question 3 from category A, Question 8 from category B, Question 9, 10, 11, 12, and 13 from category D 2. No costs are payable in respect of this motion." Filed on 13-FEB-2020 copies sent to parties entered in J. & O. Book, volume 1446 page(s) 79 - 82 Interlocutory Decision
Order dated 13-FEB-2020 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 64 Result: "THIS COURT ORDERS that: 1. No costs are payable in respect of this motion." The Court's decision is with regard to Motion Doc. No. 65 Result: same as above Filed on 13-FEB-2020 copies sent to parties entered in J. & O. Book, volume 1446 page(s) 77 - 78 Interlocutory Decision
Communication to the Court from the Registry dated 10-FEB-2020 re: draft orders IDs: 222 and 223
Draft Order concerning Motion Doc. No. 72 received on 07-FEB-2020
Draft Order concerning Motions, Doc. Nos 64 65 received on 07-FEB-2020
Acknowledgment of Receipt received from both parties (by e-mail) with respect to oral directions (ID: 220) placed on file on 31-JAN-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-JAN-2020 directing that "Teva's letter of January 30, 2020, apparently aping Apotex's similar letter of January 29, 2020, informally seeks an extension of the January 30, 2020 delay to serve motions for letters rogatory, but does not indicate whether it has the consent of the Plaintiffs. As counsel should know, that is neither appropriate nor in conformity with the Notice to the parties and the profession regarding informal requests for interlocutory relief. The Court further notes from counsel for the Plaintiffs' subsequent letter that Teva did not consult with it prior to sending its letter to the Court. The Court will not entertain Teva's informal request and expects that Teva will in future refrain from such conduct." placed on file on 31-JAN-2020 Confirmed in writing to the party(ies)
Letter from Plaintiffs dated 31-JAN-2020 in response to ID 217. Scanned to CMJ 31-Jan-2020 received on 31-JAN-2020
Communication to the Court from the Registry dated 30-JAN-2020 re: Defendant's letter ID: 217
Letter from Defendant dated 30-JAN-2020 "(...) In light of the Plaintiffs' ongoing inter partes testing and the second round of examinations for discovery scheduled for February 12-13, 2020, Teva requests that the deadline set out in the September 23, 2019 Scheduling Order be extended until ten (10) days following the delivery of all materials related to the inter partes testing being carried out by the Plaintiffs." received on 30-JAN-2020
Ottawa 29-JAN-2020 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 72 on behalf of Plaintiffs Result of Hearing: Matter partially granted held in Court Duration per day: 29-JAN-2020 from 01:29 to 02:44 Courtroom : Conference Room 1103, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Emily Price Total Duration: 1h13min Appearances: Mr. Ryan Steeves and Mr. Ben Pearson 613-233-1781 representing Plaintiffs Ms. Faylene Lunn 613-787-1025 representing Defendant Draft Decision to be submitted by parties Comments: DARS was used to record this hearing. Minutes of Hearing entered in Vol. 1040 page(s) 209 - 212 Abstract of Hearing placed on file
Copy of Notice of Appeal (Appeal Court File No. A-16-20 ) appealing the Order of Justice Pentney dated 31-OCT-2019 filed in the Court of Appeal on 14-JAN-2020 on behalf of Apotex Inc. (Defendant in T-2093-18) placed on file on 15-JAN-2020
Copy of Notice of Appeal (Appeal Court File No. A-15-20 ) appealing the Order of the Honourable Justice Pentney dated 31-OCT-2019 filed in the Court of Appeal on 14-JAN-2020 on behalf of Teva Canada Limited placed on file on 15-JAN-2020
Book of Authorities (re Motion to Compel) consisting of 1 volume(s) on behalf of Plaintiffs received on 07-JAN-2020
Covering letter from Plaintiff dated 24-JAN-2020 concerning attached USB stick containing documents for the hearing on January 29, 2020 placed on file on 27-JAN-2020
Solicitor's certificate of service on behalf of Ryan Steeves confirming service of 72, 73, 74, 75 upon Defendant by e-mail on 23-JAN-2020 filed on 24-JAN-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 24-JAN-2020
Sealed envelope pursuant to Protective agreement effect March 11, 2019 on behalf of Plaintiff purporting to contain Affidavit of Susan Burkhardt Filed on 24-JAN-2020
Plaintiffs' motion to compel, Pleadings filed on 24-JAN-2020
Sealed envelope pursuant to Protective agreement of March 11, 2019 on behalf of Plaintiff purporting to contain Plaintiff's Refusal Chart from the Examination of discovery of Dr. Mathi Mathivanan on behalf of the defendant. Filed on 24-JAN-2020
Notice of Motion on behalf of Plaintiff returnable at Special Sitting in Ottawa on 29-JAN-2020 to begin at 01:30 for an Order requiring Teva to provide answers to refusals from examination of Discovery. This will be heard by Prothonotary Tabib. filed on 24-JAN-2020
Letter sent by Registry on 17-JAN-2020 to Defendant's counsel (Dr. Faylene Lunn) enclosing a copy of the audio recording of the Federal Court proceeding heard in Toronto on January 8, 2020, and in Ottawa on January 9 and 10, 2020 before Madam Prothonotary Mireille Tabib. Copy placed on file.
Request for a copy of DARS recording received from counsel for the Defendant (Ms. Faylene Lunn - Osler, Hoskin & Harcourt LLP), for a proceeding heard in Toronto and Ottawa on January 8-10, 2020. placed on file on 16-JAN-2020
Covering letter from Defendant dated 24-JAN-2020 concerning Doc. Nos. 70 71 placed on file on 24-JAN-2020
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of doc. #70 upon Plaintiff by email on 23-JAN-2020 filed on 24-JAN-2020
Motion Record in response to Motion Doc. No. 65 containing the following original document(s): 69 Number of copies received: 3 on behalf of Defendant (2 VOLUMES) filed on 24-JAN-2020
Written Submissions (in a sealed envelope pursuant to Direction dated 8-JAN-2020) contained within a Motion Record on behalf of Defendant concerning Motion in writing Doc. No. 65 filed on 24-JAN-2020
Ottawa 09-JAN-2020 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Motion Doc. No. 64 on behalf of Defendant and Motion Doc. no. 65 on behalf of the DEfendant Result of Hearing: Matters partially granted - Order and Reasons to follow held in Court Senior Usher: Pierre Gendron Duration per day: 09-JAN-2020 from 09:39 to 05:12 Courtroom : Conference Room 1103, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Emily Price 10-JAN-2020 from 09:07 to 11:42 Courtroom : Courtroom - 5th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Emily Price Total Duration: 1d 2.5h Appearances: Mr. Ryan Steevs, Mr. Ben Pearson, Mr. William Foster 613-786-8678 representing Plaintiff Ms. Faylene Lunn 613-787-1101 representing Defendant Comments: DARS used to record this hearing. Minutes of Hearing entered in Vol. 1039 page(s) 462 - 481 Abstract of Hearing placed on file
Refusals Chart (CONFIDENTIAL) re motions being heard on January 8, 2020 Apotex Inc.'s and Teva Canada's Moving Positions Chart Re: Refusals and under advisements refused from Apotex Inc.'s and Teva Canada's Examination for discovery held September 9 and 10, 2019 filed on 06-JAN-2020
Refusals Chart (CONFIDENTIAL) re motions being heard on January 8, 2020 Teva Canada Limited's and Apotex Inc.'s Moving Position Chart Re: Refusals, under advisements refused from the common examination for discovery held September 26 and 27, 2019 (PARTS 1 & 2) filed on 06-JAN-2020
Refusals Chart (CONFIDENTIAL) re motions being heard on January 8, 2020 Teva Canada Limited's Moving Positions Chart Re: Refusals, under advisements refused and incomplete answeres to undertakings from Teva's examination for discovery held September 10, 2019 filed on 06-JAN-2020
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 07-JAN-2020
Notice of Motion on behalf of Defendant returnable at Special Sitting in Toronto on 08-JAN-2020 to begin at 09:30 for (Teva's Motion to Compel Answers) "1. An order directing the Plaintiffs, Bayer Inc. and Bayer Intellectual Property GmbH ("Bayer") to provide answers to undertakings and refusals from the discovery of Venessa Cocuzzoli listed in the positions chart attached as Schedule "A" to this motion. 2. Teva's costs of this motion; and 3. Such further and other relief as this Honourable Court may deem just." filed on 07-JAN-2020
Notice of Motion on behalf of Defendant returnable at Special Sitting in Toronto on 08-JAN-2020 to begin at 09:30 for (Common issues motion - T-1960-18; T-2093-18; T-435-19; T-806-19) "1. An order directing that the Plaintiffs provide answers to the questions from its examinations for discovery as set out in positions charts at Schedules "A" and "B" delivered under a separate cover to the Court. 2. Costs of this motion; and 3. Such further and other relief as this Honourable Court may deem just." filed on 07-JAN-2020
Letter from Defendant dated 10-JAN-2020 further to the Plaintiffs' letter dated January 7, 2020 (ID: 186) (scanned to CMJ: Tabib, P.) received on 10-JAN-2020
Toronto 08-JAN-2020 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Special Case Refusals Motions Result of Hearing: Adjourned to 9-Jan-2020 in Ottawa held in Court Senior Usher: Lisa Tirado Duration per day: 08-JAN-2020 from 09:34 to 16:53 Courtroom : Courtroom No. 4-C - Toronto Court Registrar: John Gornick Total Duration: 7h 19min Appearances: Mr. Ryan Steeves, Mr. Benjamin Pearson, Mr. William Foster 613-786-0159 representing Plaintiffs Ms. Faylene Lunn 613-787-1025 representing Defendant Comments: DARS used at this hearing - Heard together with T-435-19, T-2093-18 and T-806-19 Minutes of Hearing entered in Vol. 1038 page(s) 396 - 412 Abstract of Hearing placed on file
Acknowledgment of Receipt received from both parties (by e-mail) with respect to oral directions ID: 189 placed on file on 08-JAN-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 08-JAN-2020 directing that (re Defendant's letter dated January 7, 2020 ID: 187) placed on file on 08-JAN-2020 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 08-JAN-2020 re: Plaintiff's motion to compel 09-JAN-2020 at 11:00a.m.
Letter from Defendant dated 07-JAN-2020 requesting an order or direction allowing the responding chart for the Bayer's motion to be filed under seal. (scanned to CMJ: Tabib, P.) received on 07-JAN-2020
Letter from Plaintiffs dated 06-JAN-2020 advising the Court that the Defendant no longer objects to the testing of their client's product on February 11. As such, the motion for an extension of time, presently set down for January 22, 2020, is no longer necessary. (scanned to CMJ: Tabib, P.) received on 07-JAN-2020
Acknowledgment of Receipt received from both parties (by e-mail) with respect to oral directions ID:184 placed on file on 07-JAN-2020
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 07-JAN-2020 directing that "The Court does not need to review the transcript in order to prepare for the hearing and invites counsel to bring a copy of the transcript to the hearing for use as needed, instead of filing it under seal ahead of time." placed on file on 07-JAN-2020 Confirmed in writing to the party(ies)
Letter from Defendant dated 06-JAN-2020 regarding Teva's request to file a portion of a confidential transcript under seal (scanned to CMJ: Tabib, P.) received on 07-JAN-2020
Letter from Defendant dated 13-DEC-2019 requesting of an extension to the December 3 deadline to advise as to whether it consents to the extension of time to February 11, 2020 requested by Bayer to conduct polymorphic inter partes testing. (scanned to CMJ Tabib, P.) received on 13-DEC-2019
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions (ID:180) placed on file on 11-DEC-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 11-DEC-2019 directing that "Teva shall advise, by 3 pm on December 13, 2019, whether it consents to the extension of time to February 11, 2020 requested by Bayer to conduct the polymorphic inter partes testing. In the absence of a consent, the parties will provide submissions as to whether and when a further telephone conference should be held to resolve the issue, or whether the Court should rule on the requested extension on the basis of written submissions." placed on file on 11-DEC-2019 Confirmed in writing to the party(ies)
Ottawa 11-DEC-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Teva to advise by 3pm on December 13 whether it consents to the extension of time to February 11, 2020 requested by Bayer to conduct testing. held by way of Conference Call Duration per day: 11-DEC-2019 from 02:05 to 02:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Emily Price Total Duration: 20min Appearances: Mr. Christopher Van Barr, Ms. Melissa Binns and Mr. Will Boyer 613-233-1781 representing Plaintiffs Ms. Faylene Lunn 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1037 page(s) 95 - 98 Abstract of Hearing placed on file
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions ID: 177 placed on file on 09-DEC-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 09-DEC-2019 directing that "A case management telephone conference will be held, if still necessary, at 2pm on December 11, 2019." placed on file on 09-DEC-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 09-DEC-2019 re: letters IDs: 173, 174, 175
Letter from Defendant dated 08-DEC-2019 "(...) We write further to the Court's Order dated November 27, 2019 and the December 6, 2019 letter from counsel for Bayer in respect of the outstanding issues relating to Bayer's proposed inter partes testing." received on 09-DEC-2019
Letter from Plaintiffs dated 06-DEC-2019 re infringement testing and advising of the need for a joint case management conference received on 06-DEC-2019
Letter from Plaintiffs dated 06-DEC-2019 re common issues testing "(...) If the foregoing is satisfactory, there may not be a need for a joint case / trial management conference to discuss inter partes common issues. (...)" received on 06-DEC-2019
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 63 placed on file on 28-NOV-2019
Communication to the Court from the Registry dated 26-NOV-2019 re: joint CMC/TMC on 26-NOV-2019 at 9:30am
Order dated 27-NOV-2019 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: "THIS COURT ORDERS that: 1. The Plaintiffs shall provide remaining answers to outstanding undertakings on a best efforts basis by December 3, 2019. 2. The parties shall exchange charts of questions they intend to pursue through a Refusals Motion by December 13, 2019; 3. The parties shall exchange responding refusals charts by December 19, 2019. 4. Teva's refusals motion will be heard in Toronto, beginning at 9:30a.m. on January 8, 2020, concurrently with the Defendants' refusals motions in T-2093-18, T-435-19, T-806-19, for a duration not exceeding 1 day. 5. The Plaintiffs' refusals motion will be heard in Ottawa beginning at 11a.m. on January 9, 2020. 6. The Plaintiffs shall provide answers to undertakings they have agreed to answer as part of their responding refusals chart, by January 15, 2020. 7. The Plaintiffs shall provide dates of availbility for a follow-up examination of both of its representatives for one day each, but the necessity of re-attendance of its Canadian representative will be spoken to at the hearing of January 8, 2020. 8. The parties shall advise the Court, by December 6, 2019 of any outstanding issues in respect of inter partes testing and shall provide their mutual dates of availability to participate in a joint case/ trial management conference to resolve same, as needed. Filed on 27-NOV-2019 copies sent to parties entered in J. & O. Book, volume 1437 page(s) 137 - 138 Interlocutory Decision
Letter from Plaintiffs (written jointly on behalf of all parties) dated 25-NOV-2019 "(..) The following schedule represents the general agreement with respect to all refusals motion questions in T-1960-18 and T-2093-18, as well as all Common Issues refusals in all four proceedings, with the exception that Teva is in general agreement with the following dates except the possible hearing dates (...)" received on 25-NOV-2019
Ottawa 26-NOV-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial Management Conference and Case Management Conference (Madam Prothontary Tabib also presiding) Result of Hearing: Order to follow. held by way of Conference Call Duration per day: 26-NOV-2019 from 09:33 to 10:57 Courtroom : Judge's Chambers - Ottawa Court Registrar: Emily Price Total Duration: 1h24min Appearances: Mr. Christopher Van Barr, Mr. Will Boyer and Ms. Melissa Binns (613) 233-1781 representing Plaintiffs Mr. J. Bradley White, Ms. Faylene Lunn and Ms. Lillian Wallace 613-787-1101 representing Defendant Comments: Held in Room 1114 Minutes of Hearing entered in Vol. 1036 page(s) 49 - 59 Abstract of Hearing placed on file
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions ID:166 placed on file on 14-NOV-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-NOV-2019 directing that "Counsel for the Plaintiff's letter of November 13, 2019 explains why the Plaintiff needed an extension to November 19, but not why it is unable to provide such answers as are available by November 15, 2019, on the condition that the Plaintiff communicate to the Defendants such answers as are available by November 15, 2019." placed on file on 14-NOV-2019 Confirmed in writing to the party(ies)
Letter from Plaintiffs dated 12-NOV-2019 "(...) We write further to the Court's Direction dated November 12, 2019 which followed the Plaintiffs' November 8, 2019 correspondence and the Defendants' November11, 2019 response. (...)" received on 13-NOV-2019
Acknowledgment of Receipt received from Plaintiffs (by e-mail) with respect to oral directions ID:163 placed on file on 13-NOV-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 12-NOV-2019 directing that "The compromise suggested at page 3 of Apotex's counsel's letter of November 11 appears reasonable to the Court. Unless Bayer can provide reasons why it is unacceptable, the Court proposes to adopt it. Bayer is to indicate its intention by 2pm on November 13, 2019." placed on file on 12-NOV-2019 Confirmed in writing to the party(ies)
Letter from Apotex (on behalf of all Defendants T-2093-18/T-1960-18/T-435-18/T-806-19) dated 12-NOV-2019 "(...) We write further to the Plaintiffs' November 8, 2019 letter requesting an extension until November 19, 2019 to provide responses to the undertakings from the examinations of Bayer Inc. and Bayer IP GmbH obtained to date. (...)" received on 12-NOV-2019
Letter from Plaintiffs dated 08-NOV-2019 "(...) Pursuant to the Scheduling Orders in T-1960-18 and T-2093-18, answers to undertakings are scheduled to be provided by November 8, 2019. The Plaintiffs' hereby request an extension until November 19, 2019 to provide responses to the undertakings from the examinations of Bayer Inc. and Bayer IP GmbH obtained to date. It is our understanding that the Defendants are not agreeable to this extension and wish to correspond separately to the Court in this regard. (...)" received on 12-NOV-2019
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Reasons for Order and Order dated 31-OCT-2019 (doc. no. 62) placed on file on 01-NOV-2019
Reasons for Order and Order dated 31-OCT-2019 rendered by The Honourable Mr. Justice Pentney Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 36 Result: "THE COURT ORDERS that: 1. The Plaintiffs do not require leave of the Court pursuant to the 2016 Notice to the Profession re Experimental Testing in order to lead evidence at trial about the 2017 dog testing. 2. In light of my conclusion on the first question, it is not necessary to answer the second question. 3. No costs are awarded." Filed on 31-OCT-2019 copies sent to parties Interlocutory Decision Certificate of Order and Reasons entered in J. & O. Book, volume 1431 page(s) 273 - 275
Copy of Notice of Appeal (Appeal Court File No. A-389-19 ) appealing Order of Justice Pentney dated August 1, 2019. filed in the Court of Appeal on 08-OCT-2019 on behalf of Teva Canada Limited placed on file on 11-OCT-2019
Solicitor's certificate of service on behalf of Ben Pearson confirming service of the Fresh as Amended Reply to Fresh as Amended Statement of Defence (doc. no. 60) upon Defendant by e-mail (Notice of Consent to Electronic Service filed 19-NOV-2018) on 07-OCT-2019 filed on 07-OCT-2019
Fresh as Amended Reply to Fresh as Amended Statement of Defence on behalf of the Plaintiffs filed on 07-OCT-2019
Covering letter from Defendant dated 26-SEP-2019 concerning Doc. Nos. 56 57 58 59 placed on file on 26-SEP-2019
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of doc. nos. 56, 57 and 58 upon Plaintiffs by e-mail on 26-SEP-2019 filed on 26-SEP-2019
Fresh as Amended Statement of Defence on behalf of Teva Canada Limited filed on 26-SEP-2019
Consent on behalf of all parties to the discontinuance of the within counterclaim on a without costs basis. filed on 26-SEP-2019
Discontinuance of the Counterclaim on Consent on behalf of Defendant / Plaintiff by Counterclaim with consent on behalf of Plaintiffs / Defendants by Counterclaim filed on 26-SEP-2019
Acknowledgment of Receipt received from both parties (by e-mail) with respect to Order doc. no. 55 placed on file on 23-SEP-2019
Order dated 23-SEP-2019 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: "THIS COURT ORDERS THAT: 1. Examinations for discovery shall be completed by September 30, 2019. 2. The parties shall exchange undertakings charts by October 1, 2019, or two weeks after the final examination if examinations are conducted after September 24, 2019. 3. Answers to undertakings shall be provided by NOvember 8, 2019. (...) Filed on 23-SEP-2019 copies sent to parties entered in J. & O. Book, volume 1426 page(s) 406 - 410 Interlocutory Decision
Communication to the Court from the Registry dated 18-SEP-2019 re: draft amended scheduling order
Letter from Plaintiff dated 17-SEP-2019 "(...) The parties have conferred and agreed upon the enclosed draft amended scheduling order. (...)" received on 17-SEP-2019
Acknowledgment of Receipt received from both parties (by e-mail) with respect to Order doc. no. 54 placed on file on 13-SEP-2019
Order dated 13-SEP-2019 rendered by The Honourable Mr. Justice Pentney Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: "THE COURT ORDERS that 1. The trial shall proceed in the following manner: a. Trial of common issues: i. September 1-4, 2020 - issues not relating to the 113 patent ii. September 8-11, 2020 - issues relating to all of the patents, including the 113 patent ** iii. September 15-16, 2020 - Closing submissions - trial of common issues: The issues of claims construction and validity shall proceed as a common hearing; (** Taro is to advise prior to the hearing on September 8, 2020, whether they intend to rely on any expert evidence filed, or lead any other factual evidence in relation to the other patents) b. Teva - Infringement: i. September 17-18, 2020 - evidence ii. September 21, 2020 (*September 22, 2020 if needed) - closing arguments c. Apotex - Infringement: i. October 5-6, 2020 - evidence ii. October 8, 2020 (*October 9, 2020 if needed) - closing arguments 2. The dates for the infringement portions of the Taro and Sandoz matters will be set for early 2021, in consultation with the parties and the judicial administrator. 3. The venue for the trial of common issues will be Toronto, Ontario. The heaering of the Teva infringement evidence will be tentatively set for Toronto, Ontario (subject to submissions from counsel for Bayer and Teva as to whether they would prefer to hold this in Ottawa, Ontario). The hearing of the closing arguments on the Teva infringement matter will be set for Ottawa, Ontario." Filed on 13-SEP-2019 copies sent to parties entered in J. & O. Book, volume 1425 page(s) 348 - 353 Interlocutory Decision
Ottawa 12-SEP-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Continuation of the Trial Management Conference Result of Hearing: matter adjourned to November 26, 2019 held in chambers Duration per day: 12-SEP-2019 from 01:31 to 01:53 Courtroom : Judge's Chambers - Ottawa Court Registrar: Emily Price Total Duration: 22min Appearances: Mr. Christopher Van Barr, Mr. Will Boyer, and Ms. Melissa Binns (613) 786-0159 representing Plaintiff Mr. J. Bradley White and Ms. Faylene Lunn (613) 787-1025 representing Defendant Minutes of Hearing entered in Vol. 1030 page(s) 345 - 347 Abstract of Hearing placed on file
Covering letter from Plaintiffs' counsel dated 05-SEP-2019 concerning Public Versions of Rule 220 motion material placed on file on 05-SEP-2019
Public Version of Doc. #31 on behalf of the Plaintiffs received on 05-SEP-2019
Public Version of the Supplemental Written Representations of the Defendants (Re: Motion to Strike the Further Evidence served in the PLaintiffs' Rule 220 Motion) doc. no. 47 (1 volume) received on 05-SEP-2019
Public Version of ID#92 (Joint Book of Documents - 7 Volumes) received on 05-SEP-2019
Ottawa 09-SEP-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Continuation of the Trial Management Conference and Case Management Conference (Madam Prothonotary Mireille Tabib also presiding) Result of Hearing: Parties to provide draft scheduling Order to the Court by September 16, 2019 held by way of Conference Call in room 1147 Duration per day: 09-SEP-2019 from 02:05 to 02:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Emily Price Total Duration: 50min Appearances: Mr. Van Barr, Mr. Boyer, Mr. Pearson and Mr. Binns 613-233-1781 representing Plaintiffs Mr. White, Ms. Lunn and Ms. Wallace 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1030 page(s) 241 - 249 Abstract of Hearing placed on file
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral directions (ID:137) placed on file on 09-SEP-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-SEP-2019 directing that "In preparation for the case management telephone conference sheduled to take place at 2 pm on September 9, 2019, the parties should note that the Court intents to address the following issues: a) Setting the dates for the common portions of the trials; b) Setting the dates for the individual portions of the Teva and Apotex trials; c) Discussing potential dates for the individual portions of the Taro and Sandoz trials. d) Discussing venue(s) for the various portions of the trials; e) Procedure for briefing furture motions on common issues. The parties are asked to communicate to the Court, jointly if possible, or otherwise individually, any other issue they believe should be discussed, by 11:30 am on September 9, 2019." placed on file on 06-SEP-2019 Confirmed in writing to the party(ies)
Ottawa 05-SEP-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Motion Doc. No. 36 on behalf of Plaintiffs Result of Hearing: Matter reserved held in Court Senior Usher: Steve Desrosiers & Michel Deslauriers Duration per day: 05-SEP-2019 from 09:30 to 04:45 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Valerie Jean-Gilles Total Duration: 1d Appearances: Ms. Melissa Binns, Mr. Will Boyer, Ms. Charlotte Dong & Ms. Natalia Thawe (613) 233-1781 representing Plaintiffs Mr. J. Bradley White & Dr. Faylene Lunn (613) 787-1101 representing Defendant (Teva Canada Ltd.) Mr. Harry Radomski, Mr. Sandon Shogilev & Mr. Carl Scott (416) 979-2211 representing Defendant (Apotex Inc.) Ms. Kavita Ramamoorthy (416) 795-8635 representing Defendant (Taro Pharmaceuticals Inc.) Ms. Kelly McClellan (416) 777-0888 representing Defendant (Sandoz Canada Inc.) Minutes of Hearing entered in Vol. 1030 page(s) 180 - 188 Abstract of Hearing placed on file
Covering letter from Plaintiff dated 19-AUG-2019 concerning Motion Record of the Plaintiffs Bayer Inc. and Bayer IP GmbH Confidential Transcripts of the Plaintiffs Bayer Inc. and Bayer IP GmbH Orders Brief of the Plaintiffs. placed on file on 19-AUG-2019
Solicitor's certificate of service on behalf of Melissa A. Binns confirming service of Motion Record of the Plaintiffs Bayer Inc. and Bayer IP GmbH Confidential Transcripts Brief of the Plaintiffs Bayer Inc and Bayer IP GmbH upon Defendant by electronic Service pursuant to consent dated 19-NOV-2018. on 19-AUG-2019 filed on 19-AUG-2019
Covering letter from Plaintiff dated 30-AUG-2019 concerning BOOK OF AUTHORITIES OF PLAINTIFF placed on file on 30-AUG-2019
Affidavit of service of NATALIA THAWE sworn on 30-AUG-2019 on behalf of Plaintiff confirming service of BOOK OF AUTHORITIES OF PLAINTIFF upon Defendant by EMAIL on 27-AUG-2019 filed on 30-AUG-2019
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 30-AUG-2019 Sent directly to Presiding Judge
Acknowledgment of Receipt received from all parties (by e-mail) with respect to oral direction ID:129 placed on file on 29-AUG-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 29-AUG-2019 directing that "As discussed at the hearing of the motion to strike affidavits, it appears that only those documents or portions of documents that disclose the details of the testing and data may be subject to claims of confidentiality. That information was not relevant to the Court's analysis and determination of the motion, and may be treated confidentially. The Plaintiff is to identify the specific pages, tabs and/or volumes of the parties' respective motion records, transcript briefs and book of documents that contain such information and shall arrange for a public version of the records to be placed on the Court's record with the allegedly confidential information removed or redacted. To avoid unecessary duplication, the Plaintiffs shall retrieve from the Court one copy of the volumes filed, from which they can remove or redact the relevant pages or portion, and which they can thereafter file as a public copy. The Plaintiffs are to file the public version by no later than September 5, 2019." placed on file on 29-AUG-2019 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from all parties (by e-mail) with respect to Order doc. no. 51 placed on file on 29-AUG-2019
Order dated 29-AUG-2019 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 24 Result: "THIS COURT ORDERS that: 1. Paragraphs 12(b) and 27, the last sentence of paragraphs 49, and paragraphs 78 and 79 of the Lança affidavit are struck. 2. The Defendants' motions are otherwise dismissed with costs payable to the Plaintiffs in the amount of 5000$ by Teva and 5000$ by Apotex, payable forthwith." Filed on 29-AUG-2019 copies sent to parties entered in J. & O. Book, volume 1424 page(s) 16 - 22 Interlocutory Decision
Covering letter from Defendant dated 27-AUG-2019 concerning Doc. Nos. 49 50 placed on file on 27-AUG-2019
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Responding Motion Record and Book of Authorities upon Plaintiff by email on 27-AUG-2019 filed on 27-AUG-2019
Book of Authorities consisting of 2 volume(s) on behalf of Defendant received on 27-AUG-2019
Sealed envelope pursuant to the Amended Order dated June 25, 2019 on behalf of Defendant purporting to contain written representations of Respondent Teva Canada Filed on 27-AUG-2019
Ottawa 28-AUG-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 24 on behalf of Defendant to Strike the Affidavits of Dr. James Polli and Dr. Jose Lanca. Result of Hearing: Matter partially granted held in Court Room 1104 Senior Usher: Michel Deslauriers Duration per day: 28-AUG-2019 from 09:30 to 12:11 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Emmanuel Eikenberry Total Duration: 2h41min Appearances: Ms. Melissa Binns, Mr. Will Boyer and Ms. Natalia Thawe 613-233-1781 representing Plaintiff Mr. J. Bradley White and Dr. Faylene Lunn 613-787-1101 representing Defendant Mr. Sandon Shogilev 416-979-2211 representing Defendant Comments: DARS used to record this hearing. Minutes of Hearing entered in Vol. 1029 page(s) 418 - 424 Abstract of Hearing placed on file
Affidavit of service of Lisa Ebdon sworn on 21-AUG-2019 on behalf of Defendant confirming service of doc 47 upon Plaintiff by email on consent on 21-AUG-2019 filed on 26-AUG-2019
Sealed envelope pursuant to Direction dated 13-MAY-2019 on behalf of Defendant purporting to contain Supplemental Written Representations (re:motion doc 24) Filed on 26-AUG-2019
Orders Brief of the Plaintiffs received on 19-AUG-2019
Sealed envelope pursuant to Court's Direction dated 22-AUG-2019 on behalf of Plaintiffs purporting to contain Confidential Transcripts Brief of the Plaintiffs Received on 19-AUG-2019
Sealed envelope pursuant to Court's Direction dated 22-AUG-2019 on behalf of Plaintiffs purporting to contain Motion Record Plaintiffs' Motion for Determination of Admissibility pursuant to Rule 220 (8 Volumes) Containing the following Documents: 36, 37, 38, 39, 40, 41, 42, 43, 44, 45. Filed on 19-AUG-2019
Written Representations contained within a Motion Record on behalf of Plaintiffs concerning Motion Doc. No. 36 filed on 19-AUG-2019
Affidavit of JAMES POLLI (CONFIDENTIAL) sworn on 25-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to E filed on 19-AUG-2019
Affidavit of JOSÉ LANCA (CONFIDENTIAL) sworn on 26-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to C filed on 19-AUG-2019
Affidavit of LISA EBDON (CONFIDENTIAL) sworn on 15-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to L filed on 19-AUG-2019
Affidavit of ARTHUR H. KIBBE (CONFIDENTIAL) sworn on 15-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to K filed on 19-AUG-2019
Affidavit of FAKHREDDIN JAMALI (CONFIDENTIAL) sworn on 15-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to V filed on 19-AUG-2019
Affidavit of JOHN C. CARTER (CONFIDENTIAL) sworn on 15-JUL-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to G filed on 19-AUG-2019
Affidavit of SUSAN BUKHARDT (CONFIDENTIAL) sworn on 27-JUN-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to FF filed on 19-AUG-2019
Affidavit of SHAWN PETRIK (CONFIDENTIAL) sworn on 27-JUN-2019 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 36 with Exhibits A to D filed on 19-AUG-2019
Notice of Motion contained within a Motion Record on behalf of Plaintiffs returnable at Special Sitting in Ottawa on 05-SEP-2019 to begin at 09:30 for An Order on consent of all parties that the Plaintiffs are authorized to seek determination of the following questions of admissibility pursuant to Rule 220 of FCR. (Please see Notice of Motion for more details) filed on 19-AUG-2019
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 22-AUG-2019 directing that "Yes, the Registry can accept the Confidential Motion Record for filing." placed on file on 23-AUG-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 22-AUG-2019 re: Confidential Motion Records of Plaintiffs, Confidential Transcripts Brief of the Plaintiffs; and Order Brief of the Plaintiffs.
Communication to the Court from the Registry dated 22-AUG-2019 re: Notice of Motion on behalf of Defendant for an Order striking certain docs.
Covering letter from Plaintiff dated 13-AUG-2019 concerning Doc. No. 31 placed on file on 13-AUG-2019
Solicitor's certificate of service on behalf of Benjamin Pearson confirming service of Doc #31 upon Defendant by email on 13-AUG-2019 filed on 13-AUG-2019
PUBLIC VERSION of Responding Motion Record of the Plaintiffs (Doc#31) filed on 13-AUG-2019
Sealed envelope pursuant to Doc #32 on behalf of Plaintiffs purporting to contain Confidential Transcripts Brief of the Plaintiffs Filed on 13-AUG-2019
Transcript of the Plaintiffs RE: PUBLIC VOLUME filed on 13-AUG-2019
Sealed envelope pursuant to ID 95 on behalf of Plaintiffs purporting to contain Responding Motion Record Containing Doc #29 Filed on 13-AUG-2019
****** CANCELLED ****** Motion Record in response to Motion Doc. No. 24 containing the following original document(s): 29 Number of copies received: 3 on behalf of Plaintiffs filed on 13-AUG-2019
Written Representations CONFIDENTIAL contained within a Motion Record on behalf of Plaintiffs concerning Motion Doc. No. 24 filed on 13-AUG-2019
Letter from Plaintiff dated 06-AUG-2019 asking for a direction similar to the direction dated May 13, 2019 from T-2093-18 re: confidential motion records received on 06-AUG-2019
Covering letter from Defendant dated 06-AUG-2019 concerning Doc Nos. 27 and 28, IDs 91 and 92 placed on file on 06-AUG-2019
Solicitor's certificate of service on behalf of Lilian Wallace confirming service of Motion record (Motion to Strike), Book of Authorities, Joint Book of Docs upon plaintiffs by email on 06-AUG-2019 filed on 06-AUG-2019
Teva and Apotex Joint Book of Documents (re: Motion to Strike the Plaintiffs Further Evidence served in respect to the Plaintiffs' Rule 220 Motion) 7 volumes received on 06-AUG-2019
Book of Authorities consisting of 2 volume(s) on behalf of Defendant received on 06-AUG-2019
Motion Record containing the following original document(s): 24 25 26 Number of copies received: 3 on behalf of Defendant filed on 06-AUG-2019
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 24 filed on 06-AUG-2019
Affidavit of Ryan Howes sworn on 06-AUG-2019 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 24 with Exhibits A, B, C filed on 06-AUG-2019
Notice of Motion contained within a Motion Record on behalf of Defendant returnable at General Sitting in Ottawa on 28-AUG-2019 to begin at 09:30 duration: 2h language: E for an Order 1. striking: (a) The Affidavit of Dr.James Polli sworn July 25, 2019 in its entirety; and (b)_The Affidavit of Dr. A. José Lança sworn July 26, 2019 in its entirety; 2. Costs of this motion; and 3. Any further and other relief as this Court may deem just. filed on 06-AUG-2019
Acknowledgment of Receipt received from all parties - by email with respect to Order and Reasons of the Court (Pentney, J.) dated August 1, 2019 placed on file on 01-AUG-2019
Reasons for Order and Order dated 01-AUG-2019 rendered by The Honourable Mr. Justice Pentney Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: "THIS COURT ORDERS that: 1. The trial of common issues in Bayer Inc et al v Taro Pharmaceuticals Inc (T-435-19) and Bayer Inc et al v Sandoz Canada Inc (T-806-19) shall be heard together with the trial of common issues previously set for Bayer Inc et al v Teva Canada Limited (T-1960-18 and Bayer Inc et al v Apotex Inc (T-2093-18). 2. The trial preparations shall continue in accordance with the schedule currently set for the Teva and Apotex matters." Filed on 01-AUG-2019 copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1421 page(s) 109 - 111
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-JUL-2019 directing that Both extensions granted, on consent placed on file on 31-JUL-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 30-JUL-2019 re: Plaintiff's letters dated July 26, 2019
Letter from Plaintiff dated 26-JUL-2019 the parties propose that the deadline be deferred to two weeks following any discovery motions and, in any event, no later than December 17, 2019 to advise the Court whether the parties are interested in participating in a DRC. received on 26-JUL-2019
Letter from Plaintiff dated 26-JUL-2019 the parties request a short indulgence until July 31, 2019 to provide proposed amended scheduling orders received on 26-JUL-2019
Letter from Plaintiff dated 24-JUL-2019 requesting the Court's direction with issues relating to the Rule 220 motion received on 24-JUL-2019
Letter from Respondent Apotex dated 25-JUL-2019 further to the Plaintiff's letter dated July 24 request the Court's direction with respect to reply evidence that the Plaintiffs intend to serve in support of the Plaintiff;s Rule 220 motion being heard September 5 received on 25-JUL-2019
Ottawa 29-JUL-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the motion to strike part of the affidavit of Bayer will be heard on August 28, 2019 at the general sittings. The moving motion record is to be served and filed by August 6 and the responding record on August 13, 2019 held by way of Conference Call in chambers Duration per day: 29-JUL-2019 from 02:00 to 02:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 45min Appearances: Mr. Van Barr 613-786-0159 representing Plaintiff Ms. Lunn 613-787-1025 representing Teva Ms. Ramamoorthy 647-795-8635 representing Taro Mr. Radomski 416-597-4142 representing Apotex Ms. McClelland 416-777-0888 representing Sandoz Minutes of Hearing entered in Vol. 1028 page(s) 346 - 349 Abstract of Hearing placed on file
Ottawa 25-JUL-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: matter adjourned to July 29, 2019 at 2:00 held by way of Conference Call in chambers Duration per day: 25-JUL-2019 from 10:00 to 11:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 1h20 Appearances: Mr. Van Barr, Mr. Boyer, Mrs. Binns, Mrs. Thawe 613-786-0159 representing Plaintiff Mr. White, Mrs. Lunn, Mrs. Wallace 613-787-1025 representing Defendant Mrs. Ramamoorthy and Mr. Wallwork 647-795-8635 representing Defendant Mr. Radomski and Mr. Shogilev 416-597-4142 representing Defendant Mrs. Hitchman, Mrs. McClelland and Mrs. Zilic 416-777-0888 representing Defendant Comments: The Court grants the parties request for an extension of two days to serve and file the motion records for the hearing of September 5, 2019 (see Amended Order dated June 25, 2019) Minutes of Hearing entered in Vol. 1028 page(s) 333 - 339 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-JUL-2019 directing that "A case management telephone conference will be held at 10:00 a.m. on July 25, 2019." placed on file on 18-JUL-2019 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 17-JUL-2019 requesting a CMC to attempt to resolve an impasse between the parties with respect to scheduling of examinations for discovery. (...) received on 17-JUL-2019
Letter from Apotex dated 08-JUL-2019 further to the Direction of the Court - Apotex will not object to the attendance of Taro and Sadoz during Apotex and Teva's examination. (...) received on 08-JUL-2019
Letter from Defendant dated 08-JUL-2019 in response to the Court's direction dated July 8, 2019 received on 08-JUL-2019
Acknowledgment of Receipt received from both parties with respect to ID 69 placed on file on 08-JUL-2019
Acknowledgment of Receipt received from both parties with respect to ID 70 placed on file on 08-JUL-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 05-JUL-2019 directing that the parties will advise, by no later than July 8, 2019, whether a motion or motions will be brought to resolve the issues surrounding the attendance of Taro and Sandoz at the discovery of Bayer's representatives and of the inventors, and if so, propose a schedule and advise of the parties' proposed hearing dates as between July 18, 19(am), 22(am) or 23(am in Toronto) placed on file on 08-JUL-2019 Confirmed in writing to the party(ies)
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 05-JUL-2019 directing that the parties are required to provide a proposed amended schedule for the next steps in this action, including, setting a date by which parties will report as to the need and proposed schedule for motions for production from non-parties or to examine non-parties, motions and deadlines arising from discovery, notice to admit facts and responses placed on file on 08-JUL-2019 Confirmed in writing to the party(ies)
Ottawa 05-JUL-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Case Management Conference and Trial Management Conference Result of Hearing: Direction to follow held in Court by way of Conference Call Duration per day: 05-JUL-2019 from 10:00 to 11:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 2h Appearances: Christopher Van Barr, Will Boyer, Ben Pearson, Natalia Thawe 613-233-1781 representing Plaintiffs Bradley White, Faylene Lunn and Lillian Wallace 613-235-7234 representing Defendant Comments: Mr. Justice Pentney joined the call at 11:08. The hearing took place in Room 1147 Minutes of Hearing entered in Vol. 1027 page(s) 305 - 310 Abstract of Hearing placed on file
Letter from Defendant dated 21-JUN-2019 the following if a brief outline of the basis for the position of Teva and Apotex that Taro and Sandoz should not be involved in the hearing of common issues (...) including schedule "1" comparative timelines of the Teva, Apotex, Taro and Sandoz cases. received on 21-JUN-2019
Letter from Plaintiff dated 26-JUN-2019 relating to Bayer's motion relating to the admissibility of its pre-litigation experimental testing. (...) received on 26-JUN-2019
Letter from Plaintiff dated 25-JUN-2019 re: seeking consent from the Plaintiff's clients to allow the Defendant in the four proceedings to discuss the Plaintiff's confidential information (...)_ received on 25-JUN-2019
Solicitor's certificate of service on behalf of Benjamin Pearson confirming service of Doc 21 upon Defendant by email on 28-JUN-2019 filed on 28-JUN-2019
Notice of Motion on behalf of Plaintiffs returnable at Special Sitting in Ottawa on 05-SEP-2019 to begin at 09:30 for an Order seeking a determination of the following questions of admissibility pursuant of Rule 220 (a/b) and a second Order. filed on 28-JUN-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 26-JUN-2019 directing that ¿The parties¿ agreement as to the questions to be put to the Court is noted and the form of the questions is approved. The Court agrees with the Plaintiff¿s proposal to include as a part of the style of cause on affidavits expected to be used in support of motions filed in multiple actions, the style of cause of each of the actions for which the affidavit is expected to be used.¿ placed on file on 26-JUN-2019 Confirmed in writing to the party(ies)
Amended Order dated 25-JUN-2019 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Trial Management Conference Result: 1. Unless the parties have come to an agreement as to the exact formulation (...) Filed on 25-JUN-2019 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1415 page(s) 339 - 341 Interlocutory Decision
Order dated 24-JUN-2019 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Trial Management Conference Result: 1. Unless the parties have come to an agreement as to (...) Filed on 24-JUN-2019 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1415 page(s) 250 - 252 Interlocutory Decision
Ottawa 24-JUN-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Trial Management Conference Result of Hearing: Matter partially dismissed matter adjourned to July 5, 2019 at 10:00 a.m. held by way of Conference Call in chambers Duration per day: 24-JUN-2019 from 10:00 to 12:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 2.5h Appearances: Christopher Van Barr, Will Boyer and Melissa Binns 613-786-0159 representing Bayer Bradley White, Faylene Lunn and Lilian Wallace 613-787-1025 representing Teva Kavita Ramamoorthy and Ben Wallwork 647-795-8635 representing Taro Harry Radomski and Carol Scott 416-597-4142 representing Apotex Carol Hitchman, Kelly McClelland and Kristina Zilic 416-777-0888 representing Sandoz Comments: with case management judge presiding Minutes of Hearing entered in Vol. 1026 page(s) 467 - 467 Abstract of Hearing placed on file
Certified French language Translation of Reasons for Order and Order rendered on 14-FEB-2019 by Mireille Tabib, Prothonotary filed on 24-JUN-2019 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1415 page(s) 80 - 81 and copy placed on file.
Oral directions received from the Court: The Honourable Mr. Justice Pentney dated 20-JUN-2019 directing that ¿The Court has reviewed the correspondence received from counsel. In order to make the best use of the time set for the Case Management Conference on Monday June 24, 2019, the Court directs that counsel for Apotex and Teva consult and provide by close of business on Friday, June 21, 2019, a letter setting out their position -- and a brief outline of the basis for their position -- in regard to a possible involvement of Taro and Sandoz as parties in the hearing of common issues previously ordered in regard to Apotex and Teva. This can be done by way of bullet points, and is without prejudice to the right of either Apotex or Teva to elaborate upon or add to these submissions at the CMC on Monday June 24, 2019.¿ placed on file on 20-JUN-2019 Confirmed in writing to the party(ies)
Letter from counsel for Teva Canada Limited dated 19-JUN-2019 in response to counsel for Bayer's correspondence dated June 18, 2019 and counsel for Apotex's correspondence dated June 19, 2019 regarding the proposed agenda for the CMC/TMC to be held on June 24, 2019 received on 19-JUN-2019
Communication to the Court from the Registry dated 19-JUN-2019 re: in preparation for the joint CMC/TMC June 24, 2019.
Letter from Respondent Apotex dated 19-JUN-2019 further to the Plaintiffs' June 18, 2019 letter providing the proposed agenda for the upcoming CMC/TMC, not in agreement with their proposed agenda received on 19-JUN-2019
Letter from the Defendant Taro Pharmaceuticals Inc. dated 18-JUN-2019 in response to the Plaintiff's letter of today's date. Taro agreed with the Plaintiffs' proposed agenda for the June 24, 2019 CMC/TMC. (...) received on 18-JUN-2019
Letter from Plaintiff dated 18-JUN-2019 including proposed draft agenda for the upcoming CMC/TMC for June 24, 2019 received on 18-JUN-2019
Ottawa 10-JUN-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The Court awaits correspondence from the parties as to scheduling a further CMC held by way of Conference Call in Court Duration per day: 10-JUN-2019 from 02:00 to 03:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 1h Appearances: Christopher Van Barr, Will Boyer and Melissa Binns 613-786-0159 representing Bayer J. Bradley White, Faylene Lunn and Lilian Wallace 613-787-1025 representing Teva Kavita Ramamoorthy and Ben Wallwork 647-795-8635 representing Taro Sandon Shogilev and Dr. Carl Scott 416-597-4142 representing Apotex Carol Hitchman and Dr. Kelly McClelland 416-777-0888 representing Sandoz Minutes of Hearing entered in Vol. 1026 page(s) 52 - 56 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-JUN-2019 directing that ¿A case management telephone conference will be held at 2 pm on June 10, 2019. The Court notes however that the Federal Courts Rules contemplate a specific procedural mechanism for seeking a preliminary determination of a question of admissibility of evidence, at Rule 220 (1) (b). The parties are encouraged to discuss among themselves whether an early judicial determination of the issue by the Trial Judge might not be achieved using that provision, and if so, to canvass a schedule for discussion at the case conference. ¿ placed on file on 06-JUN-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 03-JUN-2019 re: letters ID 47 and 48
Letter from Respondent Apotex dated 31-MAY-2019 further to the Plaintiff's letter dated May 30, 2019. (...) received on 31-MAY-2019
Letter from Plaintiff dated 30-MAY-2019 requesting the Court's assistance in resolving a dispute between the parties with repect to experimental testing (...) the only mutual available date is June 10, 2019 for a CMC. received on 30-MAY-2019
Acknowledgment of Receipt received from all parties with respect to ID 45 placed on file on 29-MAY-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 29-MAY-2019 directing that "The parties' proposal is accepted." placed on file on 29-MAY-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 28-MAY-2019 re: ID 63
Letter from Plaintiff dated 25-MAY-2019 further to the scheduling Order dated February 25, 2019, for the parties to advise whether they are interested in a fully electronic trial (...) received on 25-MAY-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 17-MAY-2019 directing that ¿A joint Case Management/Trial Management Conference shall be held on June 24, 2019, at 10:00 a.m., by teleconference, for a duration of 2 hours. The parties are to consult and to provide a proposed agenda no less than 7 days in advance of this.¿ placed on file on 17-MAY-2019 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from the Plaintiffs and Defendant with respect to Order Doc. No. 17 placed on file on 14-MAY-2019
Order dated 13-MAY-2019 rendered by The Honourable Mr. Justice Pentney Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: THIS COURT ORDERS that: 1. The trial shall proceed in the following manner: a. The issues of claims construction and validity shall proceed as a common hearing; b. Immediately following that hearing, the issue of infringement for one of the Defendants will be scheduled, followed by final submissions on the issues regarding the Plaintiffs and this Defendant; c. This will be followed by a separate hearing, to be scheduled at a later date, for the issues of infringement involving the second Defendant, followed by final submissions on the issues regarding the Plaintiffs and the Defendant. 2. The judicial administrator will fix trial dates in accordance with this Order, taking into consideration the availabilities provided by the parties, and, subject to representations from the parties, so that the common issues can be heard together with Court File No. T-435-19. 3. All scheduling will be done in consultation with the Case Management Judge and the Trial Judge. Filed on 13-MAY-2019 copies sent to parties entered in J. & O. Book, volume 1410 page(s) 185 - 188 Interlocutory Decision
Communication to the Court from the Registry dated 02-MAY-2019 re: parties' correspondence dated May 2, 2019 re: motion scheduled for May 9
Letter from Plaintiff dated 02-MAY-2019 the parties in this proceeding have resolved the issues set out in the Plaintiff's motion served April 18, 2019 such that the Plaintiff's motion is no longer necessary. (...) In light of the above, the motion date of May 9, 2019 is no longer necessary in this proceeding. received on 02-MAY-2019
Letter from Plaintiff dated 12-APR-2019 in accordance with the scheduling Orders dated February 25, 2019 in T-1960-18 and T-2093-18, the parties hereby advise that they are mutually available for a joint CMC/TMC on june 11, 14, 25, 26, 2019. received on 12-APR-2019
Ottawa 03-APR-2019 BEFORE The Honourable Mr. Justice Pentney Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held by way of Conference Call in chambers Duration per day: 03-APR-2019 from 02:00 to 02:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 45mins Appearances: Christopher Van Barr, Will Boyer and Melissa Binns 613-786-0159 representing Bayer Bradley White, Faylene Lunn and Lilian Wallace 613-787-1025 representing Teva Harry Radomski and Dr. Carl Scott 416-597-4142 representing Apotex Comments: joint CMC/TMC with the case management judge present Minutes of Hearing entered in Vol. 1020 page(s) 285 - 285 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 22-MAR-2019 directing that "A joint case management/trial management telephone conference will be held at 2:00 p.m. on April 3, 2019." placed on file on 22-MAR-2019 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 08-MAR-2019 re: update as to scheduling of the joint portions of the trial with T-2093-18
Letter from Plaintiff dated 08-MAR-2019 re: joint proposal as to scheduling of trials. Requests a CMTC \ received on 08-MAR-2019
Letter from Plaintiff dated 06-MAR-2019 the parties have been in discussions and continue to discuss the issue with respect to any joint proposal, or disagreement, as to the conduct, format or scheduling of the trials of these actions. Parties ask the Court's indulgence to extend the date for response until Friday, March 8 at 2:00. received on 06-MAR-2019
Order dated 25-FEB-2019 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: The schedule set out in the order of December 13, 2018, is updated and modified as follows: 1. The parties shall revert to the Court in respect of any joint proposal or disagreement as to the conduct, format or scheduling of the joint portions of the trial in this case and in T-2093-18 by March 6, 2019. (...) Filed on 25-FEB-2019 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1400 page(s) 423 - 427 Interlocutory Decision
Ottawa 25-FEB-2019 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held by way of Conference Call in Court in chambers Duration per day: 25-FEB-2019 from 12:00 to 01:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 1h Appearances: Christopher Van Barr, Will Boyer and Melissa Binns 613-786-0159 representing Plaintiff Bradley White, Faylene Lunn and Liliane Wallace 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1018 page(s) 68 - 76 Abstract of Hearing placed on file
Communication to the Court from the Registry dated 22-FEB-2019 re: in preperation for the CMTC FEbruary 25, 2019 at 12:00 p.m.
Acknowledgment of Receipt received from all parties with respect to doc. no. 15 placed on file on 18-FEB-2019
Order and Reasons dated 14-FEB-2019 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Trial of the matter Result: 1. The trial in Court file T-1960-18 will be heard concurrently with the trial in T-2093-18, in respect of all common invalidity issues, at a time and place and for a duration to be fixed by the judicial administrator in consultation with the parties and the case management judge 2. The trials in Court file T-1960-18 and T-2093-18 in respect of all other issues will proceed seperately at times and places and for duration to be fixed by the judicial administrator in consultation with the parties and the case management judge. Filed on 14-FEB-2019 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1399 page(s) 435 - 435 Interlocutory Decision
Covering letter from Defendant dated 07-FEB-2019 concerning Doc. Nos. 12 13 filed on 07-FEB-2019
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Reply to the Defence and Counterclaim upon Plaintiff by e-mail with consent on 07-FEB-2019 filed on 07-FEB-2019
Reply to Defence to Counterclaim on behalf of Defendant Filed on 07-FEB-2019
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-JAN-2019 directing that "At the Court's request, counsel for Teva in T-1960-18 has been invited to attend the case management telephone conference of February 1, 2019 at 9:30 a.m., and has confirmed their availability. Counsel for Bayer is to ensure that a copy of its written submissions filed January 25, 2019, are forthwith provided to counsel for Teva." placed on file on 30-JAN-2019 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Ben Pearson confirming service of The Reply and Defence and Defence to Counterclaim (Doc. No. 10) upon the Defendant/Plaintiff by Counterclaim by e-mail on 28-JAN-2019 filed on 28-JAN-2019
Reply and Defence and Defence to Counterclaim on behalf of Plaintiff/Defendant by Counterclaim Filed on 28-JAN-2019
Letter from Plaintiff dated 07-JAN-2019 ? advising that they intend to adduce a portion of the trial evidence in French and request the appointment of a bilingual judge for the trial schedule to begin on September 14, 2020. received on 07-JAN-2019
Order dated 13-DEC-2018 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1.The Plaintiff shall, by January 7, 2019, advise whether they intend to adduce any trial evidence in French. In the meantime, the parties shall ensure that they remain available for a trial in Ottawa beginning on September 14, 2020 for a duration of two weeks, (...) Filed on 13-DEC-2018 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1395 page(s) 1 - 5 Interlocutory Decision
Ottawa 11-DEC-2018 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held by way of Conference Call in chambers Duration per day: 11-DEC-2018 from 03:00 to 03:41 Courtroom : Judge's Chambers - Ottawa Court Registrar: Amélie Sabourin Total Duration: 41mins Appearances: Christopher Van Barr, Will Boyer and Melissa Binns 613-786-0159 representing Plaintiff J. Bradley White and Faylene Lunn 613-787-1025 representing Defendant Minutes of Hearing entered in Vol. 1013 page(s) 199 - 204 Abstract of Hearing placed on file
Covering letter from Teva Canada Limited dated 10-DEC-2018 concerning Statement of Defence and Counterclaim placed on file on 10-DEC-2018
Solicitor's certificate of service on behalf of J. Bradley White confirming service of document #7 upon Plaintiff by email on 10-DEC-2018 filed on 10-DEC-2018
Defence and Counterclaim on behalf of Teva Canada Limited filed on 10-DEC-2018
Communication to the Court from the Registry dated 10-DEC-2018 re: CMTC December 11, 2018 at 3:00 p.m.
Letter from Plaintiff dated 07-DEC-2018 enclosing a timetable for steps leading up to trial and the dates for such trial. The parties have agreed on the timing of all items that they propose to schedule now and on items that they propose to address at a later stage in this proceeding. (...) received on 10-DEC-2018
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-NOV-2018 directing that "A case management telephone conference will be held at 3:00 p.m. on December 11, 2018." placed on file on 30-NOV-2018 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 28-NOV-2018 re: new CM file and request for CMC
Letter from Plaintiff dated 26-NOV-2018 in accordance with the Notice to the Parties and Profession dated (...) the Plaintiffs request a CMC (...) counsel are mutually available on (...) received on 26-NOV-2018
Covering letter from Defendant dated 19-NOV-2018 concerning Doc. No. 6 placed on file on 19-NOV-2018
Solicitor's certificate of service on behalf of Lillian Wallace confirming service of the Notice of intention to respond upon Plaintiff by e-mail on 19-NOV-2018 filed on 19-NOV-2018
Notice of Intention to Participate on behalf of Defendant filed on 19-NOV-2018
Covering letter from Defendant dated 19-NOV-2018 concerning Doc. No. 4 placed on file on 19-NOV-2018
Consent on behalf of Plaintiff all parties to electronic Services of all documents in this action that are not required to be personally served, and for those that are required to be personally served, if specific consent is requested and granted filed on 19-NOV-2018
Order dated 16-NOV-2018 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 09-NOV-2018 Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 16-NOV-2018 copies sent to parties entered in J. & O. Book, volume 1392 page(s) 120 - 120 Interlocutory Decision
Affidavit of service of Emily Bradley sworn on 14-NOV-2018 on behalf of Plaintiffs confirming service of doc. #1 upon Defendant by personal service on 09-NOV-2018 filed on 14-NOV-2018
Letter from Plaintiff dated 09-NOV-2018 requesting that the action be specially managed pursuant to section 6.1.(1) of the Patented Medicines Regulations Act received on 09-NOV-2018
Statement of Claim filed on 09-NOV-2018 Tariff other action - $150.00
The official version of the court proceeding information is available from the court websites directly: